|
CA1159052A
(en)
*
|
1980-02-29 |
1983-12-20 |
University Patents, Inc. |
Process for making oligonucleotides
|
|
US6692941B1
(en)
*
|
1980-08-26 |
2004-02-17 |
The Regents Of The University Of California |
Bovine growth hormone
|
|
US7101981B1
(en)
|
1980-08-26 |
2006-09-05 |
Regents Of The University Of California |
Bovine growth hormone recombinantly produced in E. coli
|
|
US4973679A
(en)
*
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
|
JPS58109498A
(ja)
*
|
1981-08-24 |
1983-06-29 |
Agency Of Ind Science & Technol |
オリゴリボヌクレオチド
|
|
EP0090789A1
(de)
*
|
1982-03-26 |
1983-10-05 |
Monsanto Company |
Chemische DNA-Synthese
|
|
CA1223831A
(en)
|
1982-06-23 |
1987-07-07 |
Dean Engelhardt |
Modified nucleotides, methods of preparing and utilizing and compositions containing the same
|
|
DE3382053D1
(de)
*
|
1982-09-30 |
1991-01-17 |
Iro Ab |
Garnspeicher- und zufuehrvorrichtung.
|
|
DE3239887A1
(de)
*
|
1982-10-28 |
1984-05-03 |
Hubert Prof. Dr. 2000 Hamburg Köster |
Verfahren zur herstellung von oligonucleotiden
|
|
US5198540A
(en)
*
|
1982-10-28 |
1993-03-30 |
Hubert Koster |
Process for the preparation of oligonucleotides in solution
|
|
FR2544720B1
(fr)
*
|
1983-04-19 |
1987-11-27 |
California Inst Of Techn |
Installation perfectionnee et procede pour la synthese de composes chimiques, en particulier d'oligonucleotides
|
|
DE3479662D1
(en)
*
|
1983-06-01 |
1989-10-12 |
Beckman Instruments Inc |
Novel preparation of nucleoside phosphoramidite intermediates
|
|
USRE34069E
(en)
*
|
1983-08-18 |
1992-09-15 |
Biosyntech Gmbh |
Process for the preparation of oligonucleotides
|
|
DE3329892A1
(de)
*
|
1983-08-18 |
1985-03-07 |
Köster, Hubert, Prof. Dr., 2000 Hamburg |
Verfahren zur herstellung von oligonucleotiden
|
|
DE3332068A1
(de)
*
|
1983-09-06 |
1985-03-21 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
|
|
US5166330A
(en)
*
|
1983-09-06 |
1992-11-24 |
Hoechst Aktiengesellschaft |
Process for the preparation of nucleoside alkyl-aralkyl- and aryl-phosphonites and -phosphonates
|
|
US5118802A
(en)
*
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
DNA-reporter conjugates linked via the 2' or 5'-primary amino group of the 5'-terminal nucleoside
|
|
US5015733A
(en)
*
|
1983-12-20 |
1991-05-14 |
California Institute Of Technology |
Nucleosides possessing blocked aliphatic amino groups
|
|
CA1244786A
(en)
*
|
1983-12-20 |
1988-11-15 |
Lloyd M. Smith |
Synthesis of amino-derivitized oligonucleotides
|
|
US5118800A
(en)
*
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
|
US5821058A
(en)
|
1984-01-16 |
1998-10-13 |
California Institute Of Technology |
Automated DNA sequencing technique
|
|
USRE43096E1
(en)
|
1984-01-16 |
2012-01-10 |
California Institute Of Technology |
Tagged extendable primers and extension products
|
|
US5367066A
(en)
*
|
1984-10-16 |
1994-11-22 |
Chiron Corporation |
Oligonucleotides with selectably cleavable and/or abasic sites
|
|
JPS61112093A
(ja)
*
|
1984-11-05 |
1986-05-30 |
Wakunaga Seiyaku Kk |
ヌクレオチド誘導体
|
|
FR2575751B1
(fr)
*
|
1985-01-08 |
1987-04-03 |
Pasteur Institut |
Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
|
|
DE3507881A1
(de)
*
|
1985-03-06 |
1986-09-11 |
Hoechst Ag, 6230 Frankfurt |
Verfahren und mittel zur phosphorylierung
|
|
US5252760A
(en)
*
|
1985-03-28 |
1993-10-12 |
Chiron Corporation |
Method of using colored phosphorylating reagents
|
|
US5332845A
(en)
*
|
1985-03-28 |
1994-07-26 |
Chiron Corporation |
Phosphorylating reagents
|
|
JPH0723393B2
(ja)
*
|
1985-05-15 |
1995-03-15 |
アモコ・コーポレーション |
シチジン同族体
|
|
US4797355A
(en)
*
|
1985-06-13 |
1989-01-10 |
Amgen Inc. |
Methods for attaching polynucleotides to supports
|
|
US4751177A
(en)
*
|
1985-06-13 |
1988-06-14 |
Amgen |
Methods and kits for performing nucleic acid hybridization assays
|
|
US4739044A
(en)
*
|
1985-06-13 |
1988-04-19 |
Amgen |
Method for derivitization of polynucleotides
|
|
WO1986007362A1
(en)
*
|
1985-06-14 |
1986-12-18 |
University Patents, Inc. |
Method for synthesizing deoxyoligonucleotides
|
|
US4757141A
(en)
*
|
1985-08-26 |
1988-07-12 |
Applied Biosystems, Incorporated |
Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
|
|
EP0216357A3
(de)
*
|
1985-09-25 |
1988-08-31 |
Nippon Zeon Co., Ltd. |
Phosphoramidit-Verbindungen und Verfahren zu deren Herstellung
|
|
US4808708A
(en)
*
|
1985-11-02 |
1989-02-28 |
Toagosei Chemical Industry Co., Ltd. |
Phosphorsulfide derivatives of deoxynucleosides or deoxynucleotides and their uses
|
|
US4855225A
(en)
*
|
1986-02-07 |
1989-08-08 |
Applied Biosystems, Inc. |
Method of detecting electrophoretically separated oligonucleotides
|
|
US5242823A
(en)
*
|
1986-03-07 |
1993-09-07 |
International Genetic Engineering, Inc. |
Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
|
|
DE3788914T2
(de)
*
|
1986-09-08 |
1994-08-25 |
Ajinomoto Kk |
Verbindungen zur Spaltung von RNS an eine spezifische Position, Oligomere, verwendet bei der Herstellung dieser Verbindungen und Ausgangsprodukte für die Synthese dieser Oligomere.
|
|
DE3751468T2
(de)
*
|
1986-10-30 |
1996-02-29 |
Daicel Chem |
Verfahren zur herstellung von oligonukleotiden und verbindungen zur bildung hochmolekularer schutzgruppen.
|
|
US5071974A
(en)
*
|
1986-10-31 |
1991-12-10 |
Amoco Corporation |
Compositions and methods for the synthesis of oligonucleotides having 5'-phosphorylated termini
|
|
US4923901A
(en)
*
|
1987-09-04 |
1990-05-08 |
Millipore Corporation |
Membranes with bound oligonucleotides and peptides
|
|
US5585481A
(en)
*
|
1987-09-21 |
1996-12-17 |
Gen-Probe Incorporated |
Linking reagents for nucleotide probes
|
|
US6031091A
(en)
*
|
1987-09-21 |
2000-02-29 |
Gen-Probe Incorporated |
Non-nucleotide linking reagents for nucleotide probes
|
|
US4965349A
(en)
*
|
1987-12-24 |
1990-10-23 |
Applied Biosystems, Inc. |
Method of synthesizing oligonucleotides labeled with ammonia-labile groups on solid phase supports
|
|
WO1989009780A1
(en)
*
|
1988-04-15 |
1989-10-19 |
Chemical Industry Institute Of Toxicology |
Site-specific tritium-labeled oligodeoxynucleotides
|
|
US5218103A
(en)
*
|
1988-05-26 |
1993-06-08 |
University Patents, Inc. |
Nucleoside thiophosphoramidites
|
|
US5278302A
(en)
*
|
1988-05-26 |
1994-01-11 |
University Patents, Inc. |
Polynucleotide phosphorodithioates
|
|
US5602244A
(en)
*
|
1988-05-26 |
1997-02-11 |
Competitive Technologies, Inc. |
Polynucleotide phosphorodithioate compounds
|
|
US5750666A
(en)
*
|
1988-05-26 |
1998-05-12 |
Competitve Technologies, Inc. |
Polynucleotide phosphorodithioate compounds
|
|
IL90359A0
(en)
*
|
1988-05-26 |
1989-12-15 |
University Patents Inc |
Nucleoside and polynucleotide thiophosphoramidite and phosphorodithioate compounds and their production
|
|
US5216141A
(en)
*
|
1988-06-06 |
1993-06-01 |
Benner Steven A |
Oligonucleotide analogs containing sulfur linkages
|
|
JPH0291088A
(ja)
*
|
1988-09-29 |
1990-03-30 |
Central Glass Co Ltd |
ホスファイトおよびヌクレオシド‐３’‐ホスファイト誘導体およびこれを用いるオリゴヌクレオチドの合成法
|
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
AU5192190A
(en)
*
|
1989-02-24 |
1990-09-26 |
City Of Hope |
Heterologous block oligomers
|
|
WO1990012022A1
(en)
*
|
1989-03-31 |
1990-10-18 |
University Patents, Inc. |
Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
|
|
US6254861B1
(en)
|
1989-05-23 |
2001-07-03 |
Chandra Choudhury |
Hematopoietic growth factor derived from T lymphocytes
|
|
DE3916871A1
(de)
*
|
1989-05-24 |
1990-11-29 |
Boehringer Mannheim Gmbh |
Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren
|
|
GR890100349A
(el)
*
|
1989-05-26 |
1994-03-31 |
University Patents Inc |
Ενώσεις νουκλεοσιδίων & πολυνουκλεοτιδίων, θειοφωσφοραμιδίων & φωσφοροδιθειικών εστέρων & μέθοδοι.
|
|
KR920701230A
(ko)
*
|
1989-06-05 |
1992-08-11 |
원본미기재 |
엑소뉴클레아제-내성 올리고뉴클레오티드 및 그 제조방법
|
|
US5256775A
(en)
*
|
1989-06-05 |
1993-10-26 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides
|
|
US6300486B1
(en)
|
1989-06-15 |
2001-10-09 |
Isis Pharmaceuticals, Inc. |
Large scale synthesis of oligonucleotides and their associated analogs
|
|
US5204455A
(en)
*
|
1989-06-15 |
1993-04-20 |
Froehler Brian C |
Monomethoxytrityl protected oligonucleotides bound to a solid support
|
|
US5164491A
(en)
*
|
1989-06-15 |
1992-11-17 |
Gilead Sciences |
Large scale synthesis of oligonucleotides and their associated analogs
|
|
US7049102B1
(en)
|
1989-09-22 |
2006-05-23 |
Board Of Trustees Of Leland Stanford University |
Multi-gene expression profile
|
|
US5545522A
(en)
|
1989-09-22 |
1996-08-13 |
Van Gelder; Russell N. |
Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
|
|
US5003097A
(en)
*
|
1989-10-02 |
1991-03-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for the sulfurization of phosphorous groups in compounds
|
|
WO1991004983A1
(en)
*
|
1989-10-05 |
1991-04-18 |
University Patents, Inc. |
Nucleoside and polynucleotide thiophosphoramidite and phosphorodithioate compounds and processes
|
|
US5914396A
(en)
*
|
1990-01-11 |
1999-06-22 |
Isis Pharmaceuticals, Inc. |
2'-O-modified nucleosides and phosphoramidites
|
|
EP0463712A3
(en)
|
1990-06-27 |
1992-04-08 |
University Patents, Inc. |
Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
|
|
US5316908A
(en)
*
|
1990-07-13 |
1994-05-31 |
Life Technologies, Inc. |
Size markers for electrophoretic analysis of DNA
|
|
DE69130331T2
(de)
*
|
1990-10-26 |
1999-03-04 |
Genta Inc., San Diego, Calif. |
Verbessertes verfahren zur synthese von oligomeren
|
|
US6605712B1
(en)
*
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
|
US5594121A
(en)
*
|
1991-11-07 |
1997-01-14 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
|
US5556961A
(en)
*
|
1991-11-15 |
1996-09-17 |
Foote; Robert S. |
Nucleosides with 5'-O-photolabile protecting groups
|
|
US8153602B1
(en)
|
1991-11-19 |
2012-04-10 |
Isis Pharmaceuticals, Inc. |
Composition and methods for the pulmonary delivery of nucleic acids
|
|
US6235887B1
(en)
|
1991-11-26 |
2001-05-22 |
Isis Pharmaceuticals, Inc. |
Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines
|
|
EP1256589A3
(de)
*
|
1991-11-26 |
2003-09-17 |
Isis Pharmaceuticals, Inc. |
Oligomere, die modifizierte PyrimIdine enthalten
|
|
TW393513B
(en)
*
|
1991-11-26 |
2000-06-11 |
Isis Pharmaceuticals Inc |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
|
EP0616612A4
(de)
|
1991-12-12 |
1995-01-11 |
Gilead Sciences Inc |
Nukleasestabile und bindungsfähige oligomere und verfahren zu ihrer verwendung.
|
|
US5644048A
(en)
*
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
|
ATE244259T1
(de)
*
|
1992-02-12 |
2003-07-15 |
Chromagen Inc |
Verwendungen von fluoreszierenden n-nukleosiden und dessen analogen
|
|
US5652099A
(en)
*
|
1992-02-12 |
1997-07-29 |
Conrad; Michael J. |
Probes comprising fluorescent nucleosides and uses thereof
|
|
US5348868A
(en)
*
|
1992-04-24 |
1994-09-20 |
Beckman Instruments, Inc. |
Methods and reagents for cleaving and deprotecting oligonucleotides
|
|
US5428148A
(en)
*
|
1992-04-24 |
1995-06-27 |
Beckman Instruments, Inc. |
N4 - acylated cytidinyl compounds useful in oligonucleotide synthesis
|
|
US5616700A
(en)
*
|
1992-04-24 |
1997-04-01 |
Beckman Instruments, Inc. |
Processes for synthesizing nucleotides and modified nucleotides using N.sub.
|
|
US5583211A
(en)
*
|
1992-10-29 |
1996-12-10 |
Beckman Instruments, Inc. |
Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides
|
|
US5955591A
(en)
*
|
1993-05-12 |
1999-09-21 |
Imbach; Jean-Louis |
Phosphotriester oligonucleotides, amidites and method of preparation
|
|
US5428149A
(en)
*
|
1993-06-14 |
1995-06-27 |
Washington State University Research Foundation |
Method for palladium catalyzed carbon-carbon coulping and products
|
|
AU697234B2
(en)
*
|
1993-06-23 |
1998-10-01 |
Viventia Biotech Inc. |
Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
|
|
US5623068A
(en)
*
|
1994-03-07 |
1997-04-22 |
Beckman Instruments, Inc. |
Synthesis of DNA using substituted phenylacetyl-protected nucleotides
|
|
US6639061B1
(en)
|
1999-07-07 |
2003-10-28 |
Isis Pharmaceuticals, Inc. |
C3′-methylene hydrogen phosphonate oligomers and related compounds
|
|
US5510476A
(en)
*
|
1994-07-07 |
1996-04-23 |
Isis Pharmaceuticals, Inc. |
Carbocation scavenging during oligonucleotide synthesis
|
|
US5552471A
(en)
*
|
1994-08-17 |
1996-09-03 |
The Perkin-Elmer Corporation |
Solid support reagents for the synthesis of 3'-Nitrogen containing polynucleotides
|
|
US5703223A
(en)
*
|
1994-09-02 |
1997-12-30 |
Thomas Jefferson University |
Solid phase synthesis of oligonucleotides with stereospecific substituted phosphonate linkages by pentavalent grignard coupling
|
|
US6558633B1
(en)
|
1994-09-21 |
2003-05-06 |
Isis Pharmaceuticals, Inc. |
Chemical reaction apparatus and methods
|
|
USRE43097E1
(en)
|
1994-10-13 |
2012-01-10 |
Illumina, Inc. |
Massively parallel signature sequencing by ligation of encoded adaptors
|
|
US5604097A
(en)
|
1994-10-13 |
1997-02-18 |
Spectragen, Inc. |
Methods for sorting polynucleotides using oligonucleotide tags
|
|
US5717085A
(en)
*
|
1994-11-23 |
1998-02-10 |
Terrapin Technologies, Inc. |
Process for preparing codon amidites
|
|
US5908926A
(en)
*
|
1995-03-16 |
1999-06-01 |
Duke University |
5'to 3' nucleic acid synthesis using 3'-photoremovable protecting group
|
|
US5750341A
(en)
|
1995-04-17 |
1998-05-12 |
Lynx Therapeutics, Inc. |
DNA sequencing by parallel oligonucleotide extensions
|
|
US5614622A
(en)
*
|
1995-06-01 |
1997-03-25 |
Hybridon, Inc. |
5-pentenoyl moiety as a nucleoside-amino protecting group, 4-pentenoyl-protected nucleotide synthons, and related oligonucleotide syntheses
|
|
US6531589B1
(en)
*
|
1995-06-01 |
2003-03-11 |
Hybridon, Inc. |
Base protecting groups and synthons for oligonucleotide synthesis
|
|
US6111095A
(en)
*
|
1995-06-07 |
2000-08-29 |
Merck & Co., Inc. |
Capped synthetic RNA, analogs, and aptamers
|
|
ATE466109T1
(de)
|
1995-06-07 |
2010-05-15 |
Solexa Inc |
Verfahren zur verbesserung der effizienz der polynukleotidsequenzierung
|
|
US5856464A
(en)
*
|
1995-06-07 |
1999-01-05 |
Lajolla Pharmaceutical Company |
Selective capping solution phase oligonucleotide synthesis
|
|
US5889136A
(en)
*
|
1995-06-09 |
1999-03-30 |
The Regents Of The University Of Colorado |
Orthoester protecting groups in RNA synthesis
|
|
EP0863910A1
(de)
*
|
1995-10-19 |
1998-09-16 |
NeXstar Pharmaceuticals, Inc. |
Verfahren zur herstellung von oligonucleotiden in lösungen
|
|
US5734041A
(en)
|
1995-10-20 |
1998-03-31 |
Mcgill University |
Preparation of chiral phosphorothioate oligomers
|
|
US6160109A
(en)
*
|
1995-10-20 |
2000-12-12 |
Isis Pharmaceuticals, Inc. |
Preparation of phosphorothioate and boranophosphate oligomers
|
|
US6476216B1
(en)
|
1995-10-20 |
2002-11-05 |
Mcgill University |
Preparation of phosphorothioate oligomers
|
|
US5705621A
(en)
*
|
1995-11-17 |
1998-01-06 |
Isis Pharmaceuticals, Inc. |
Oligomeric phosphite, phosphodiester, Phosphorothioate and phosphorodithioate compounds and intermediates for preparing same
|
|
US20030119724A1
(en)
*
|
1995-11-22 |
2003-06-26 |
Ts`O Paul O.P. |
Ligands to enhance cellular uptake of biomolecules
|
|
US5808035A
(en)
*
|
1995-12-08 |
1998-09-15 |
Usher; David A. |
Protected nucleoside and method for its synthesis
|
|
US5736626A
(en)
|
1996-01-29 |
1998-04-07 |
The Perkin-Elmer Corporation |
Solid support reagents for the direct synthesis of 3'-labeled polynucleotides
|
|
EP0932698A1
(de)
*
|
1996-03-26 |
1999-08-04 |
Lynx Therapeutics, Inc. |
Oligonukleotide zusammenstellungen zur behandlung von menschlichem melanom
|
|
US5959100A
(en)
|
1996-03-27 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Pyrimidine nucleosides as therapeutic and diagnostic agents
|
|
US6020481A
(en)
*
|
1996-04-01 |
2000-02-01 |
The Perkin-Elmer Corporation |
Asymmetric benzoxanthene dyes
|
|
US5852168A
(en)
*
|
1996-04-30 |
1998-12-22 |
Regents Of The University Of Minesota |
Sulfurization of phosphorus-containing compounds
|
|
US7812149B2
(en)
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
|
US6060240A
(en)
*
|
1996-12-13 |
2000-05-09 |
Arcaris, Inc. |
Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
|
|
US6103891A
(en)
*
|
1996-12-27 |
2000-08-15 |
Isis Pharmaceuticals, Inc. |
Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
|
|
US5955600A
(en)
*
|
1996-12-27 |
1999-09-21 |
Isis Pharmaceuticals, Inc. |
Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
|
|
US6172217B1
(en)
|
1996-12-27 |
2001-01-09 |
Isis Pharmaceuticals Inc. |
Method of synthesizing phosphorothioate oligonucleotides
|
|
US5902881A
(en)
|
1997-03-03 |
1999-05-11 |
Isis Pharmaceuticals, Inc. |
Reagent useful for synthesizing sulfurized oligonucleotide analogs
|
|
US5760209A
(en)
*
|
1997-03-03 |
1998-06-02 |
Isis Pharmaceuticals, Inc. |
Protecting group for synthesizing oligonucleotide analogs
|
|
CA2283789C
(en)
|
1997-03-12 |
2005-07-05 |
Applied Biosystems, Llc |
Dna polymerases having improved labeled nucleotide incorporation properties
|
|
WO1998044156A1
(en)
|
1997-03-27 |
1998-10-08 |
Life Technologies, Inc. |
Nucleic acid ladders
|
|
EP1001963B1
(de)
|
1997-07-15 |
2011-01-05 |
Life Technologies, Inc. |
Nukleinsäureleitern
|
|
US6008379A
(en)
|
1997-10-01 |
1999-12-28 |
The Perkin-Elmer Corporation |
Aromatic-substituted xanthene dyes
|
|
US5936087A
(en)
|
1997-11-25 |
1999-08-10 |
The Perkin-Elmer Corporation |
Dibenzorhodamine dyes
|
|
US6583168B1
(en)
|
1997-11-25 |
2003-06-24 |
Applera Corporation |
Sulfonated diarylrhodamine dyes
|
|
US6441150B1
(en)
*
|
1997-12-16 |
2002-08-27 |
Isis Pharmaceuticals, Inc. |
Compounds for the Synthesis of Nucleotide or oligonucleotide phosphoramidites
|
|
US7427678B2
(en)
*
|
1998-01-08 |
2008-09-23 |
Sigma-Aldrich Co. |
Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
|
|
US6893877B2
(en)
|
1998-01-12 |
2005-05-17 |
Massachusetts Institute Of Technology |
Methods for screening substances in a microwell array
|
|
EP2286918B1
(de)
*
|
1998-01-12 |
2014-10-01 |
Massachusetts Institute of Technology |
Verfahren zur Mikrotestdurchführung
|
|
US20020164585A1
(en)
*
|
1998-01-16 |
2002-11-07 |
Sean Chapman |
Method for enhancing RNA or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
|
|
US6303848B1
(en)
|
1998-01-16 |
2001-10-16 |
Large Scale Biology Corporation |
Method for conferring herbicide, pest, or disease resistance in plant hosts
|
|
US6426185B1
(en)
|
1998-01-16 |
2002-07-30 |
Large Scale Biology Corporation |
Method of compiling a functional gene profile in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation
|
|
US20030027173A1
(en)
*
|
1998-01-16 |
2003-02-06 |
Della-Cioppa Guy |
Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
|
|
US6080868A
(en)
|
1998-01-23 |
2000-06-27 |
The Perkin-Elmer Corporation |
Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
|
|
US6326479B1
(en)
|
1998-01-27 |
2001-12-04 |
Boston Probes, Inc. |
Synthetic polymers and methods, kits or compositions for modulating the solubility of same
|
|
US6020475A
(en)
*
|
1998-02-10 |
2000-02-01 |
Isis Pharmeuticals, Inc. |
Process for the synthesis of oligomeric compounds
|
|
US7273933B1
(en)
|
1998-02-26 |
2007-09-25 |
Isis Pharmaceuticals, Inc. |
Methods for synthesis of oligonucleotides
|
|
US6111086A
(en)
*
|
1998-02-27 |
2000-08-29 |
Scaringe; Stephen A. |
Orthoester protecting groups
|
|
US6531590B1
(en)
|
1998-04-24 |
2003-03-11 |
Isis Pharmaceuticals, Inc. |
Processes for the synthesis of oligonucleotide compounds
|
|
US6590092B1
(en)
*
|
1998-05-19 |
2003-07-08 |
Nam Q. Ngo |
Process for preparing a “universal support” and the reagents used for generating such support
|
|
US6274725B1
(en)
|
1998-06-02 |
2001-08-14 |
Isis Pharmaceuticals, Inc. |
Activators for oligonucleotide synthesis
|
|
AU4434299A
(en)
|
1998-06-11 |
1999-12-30 |
Isis Pharmaceuticals, Inc. |
Synthetic methods and intermediates for triester oligonucleotides
|
|
US6335439B1
(en)
|
1998-06-11 |
2002-01-01 |
Isis Pharmaceuticals, Inc. |
Method of preparing phosphoramidites
|
|
US6270730B1
(en)
*
|
1998-06-16 |
2001-08-07 |
Northwest Engineering Inc. |
Multi-well rotary synthesizer
|
|
US7087148B1
(en)
|
1998-06-23 |
2006-08-08 |
Clinical Micro Sensors, Inc. |
Binding acceleration techniques for the detection of analytes
|
|
US6326478B1
(en)
|
1998-07-08 |
2001-12-04 |
Isis Pharmaceuticals, Inc. |
Process for the synthesis of oligomeric compounds
|
|
US6867294B1
(en)
|
1998-07-14 |
2005-03-15 |
Isis Pharmaceuticals, Inc. |
Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages
|
|
US6242589B1
(en)
|
1998-07-14 |
2001-06-05 |
Isis Pharmaceuticals, Inc. |
Phosphorothioate oligonucleotides having modified internucleoside linkages
|
|
US6124484A
(en)
|
1998-07-17 |
2000-09-26 |
Isis Pharmaceuticals, Inc. |
Recovery of triarylmethyl halide protecting groups cleaved during oligonucleotide synthesis
|
|
US6271042B1
(en)
|
1998-08-26 |
2001-08-07 |
Alpha Innotech Corporation |
Biochip detection system
|
|
US6335437B1
(en)
|
1998-09-07 |
2002-01-01 |
Isis Pharmaceuticals, Inc. |
Methods for the preparation of conjugated oligomers
|
|
US6069243A
(en)
*
|
1998-10-06 |
2000-05-30 |
Isis Pharmaceuticals, Inc. |
Process for oligonucleotide synthesis
|
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
|
US6153411A
(en)
|
1998-10-30 |
2000-11-28 |
American Water Works Company, Inc. |
Methods and kits for detection of Cryptosporidium parvum using immunomagnetic separation and amplification
|
|
US6169177B1
(en)
|
1998-11-06 |
2001-01-02 |
Isis Pharmaceuticals, Inc. |
Processes for the synthesis of oligomeric compounds
|
|
JP4638043B2
(ja)
|
1998-12-14 |
2011-02-23 |
パシフィック バイオサイエンシーズ オブ カリフォルニア， インコーポレイテッド |
ポリメラーゼ合成による、単一分子の核酸の配列決定のためのシステムおよび方法
|
|
US6380378B1
(en)
|
1998-12-24 |
2002-04-30 |
Toagosei Company, Ltd. |
Nucleotide compound, nucleotide block oligonucleotide, and method for producing them
|
|
US6432642B1
(en)
*
|
1999-01-15 |
2002-08-13 |
Pe Corporation (Ny) |
Binary probe and clamp composition and methods for a target hybridization detection
|
|
US6465628B1
(en)
|
1999-02-04 |
2002-10-15 |
Isis Pharmaceuticals, Inc. |
Process for the synthesis of oligomeric compounds
|
|
US6207819B1
(en)
|
1999-02-12 |
2001-03-27 |
Isis Pharmaceuticals, Inc. |
Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
|
|
US6121437A
(en)
|
1999-03-16 |
2000-09-19 |
Isis Pharmaceuticals, Inc. |
Phosphate and thiophosphate protecting groups
|
|
US20040082774A1
(en)
*
|
1999-03-16 |
2004-04-29 |
Guzaev Andrei P. |
Novel phosphate and thiophosphate protecting groups
|
|
US6399765B1
(en)
*
|
1999-03-17 |
2002-06-04 |
Isis Pharmaceuticals, Inc. |
Methods for removing dimethoxytrityl groups from oligonucleotides
|
|
NZ513390A
(en)
|
1999-03-19 |
2003-01-31 |
Genencor Int |
Multi-through hole testing plate for high throughput screening
|
|
CA2370478A1
(en)
|
1999-03-24 |
2000-09-28 |
Serge L. Beaucage |
N-acylphosphoramidites and their use in oligonucleotide synthesis
|
|
US20020177135A1
(en)
*
|
1999-07-27 |
2002-11-28 |
Doung Hau H. |
Devices and methods for biochip multiplexing
|
|
US6610842B1
(en)
|
1999-05-06 |
2003-08-26 |
Isis Pharmaceuticals, Inc. |
Processes for the synthesis of oligomers using phosphoramidite compositions
|
|
US6221635B1
(en)
|
1999-05-06 |
2001-04-24 |
The Wistar Institute |
Methods for solid-phase amplification of DNA template (SPADT) using multiarrays
|
|
US6593464B1
(en)
|
1999-05-24 |
2003-07-15 |
Invitrogen Corporation |
Method for deblocking of labeled oligonucleotides
|
|
US20070059752A1
(en)
*
|
1999-06-09 |
2007-03-15 |
Biosearch Technologies, Inc. |
Fluorescence energy transfer probes with stabilized conformations
|
|
US7183405B2
(en)
|
1999-06-25 |
2007-02-27 |
Syn Gen, Inc. |
Compositions and methods for labeling oligonucleotides
|
|
US6750357B1
(en)
|
1999-06-25 |
2004-06-15 |
Syngen, Inc. |
Rhodamine-based fluorophores useful as labeling reagents
|
|
US6414135B1
(en)
|
1999-07-07 |
2002-07-02 |
Isis Pharmaceuticals, Inc. |
C3′-methylene hydrogen phosphonate monomers and related compounds
|
|
US6593466B1
(en)
|
1999-07-07 |
2003-07-15 |
Isis Pharmaceuticals, Inc. |
Guanidinium functionalized nucleotides and precursors thereof
|
|
US6346423B1
(en)
|
1999-07-16 |
2002-02-12 |
Agilent Technologies, Inc. |
Methods and compositions for producing biopolymeric arrays
|
|
US6306599B1
(en)
|
1999-07-16 |
2001-10-23 |
Agilent Technologies Inc. |
Biopolymer arrays and their fabrication
|
|
US6147200A
(en)
*
|
1999-08-19 |
2000-11-14 |
Isis Pharmaceuticals, Inc. |
2'-O-acetamido modified monomers and oligomers
|
|
US6114518A
(en)
*
|
1999-09-30 |
2000-09-05 |
Becton, Dickinson And Company |
Synthesis and use of labelled phosphoramidite compositions
|
|
WO2001025188A1
(en)
|
1999-10-04 |
2001-04-12 |
University Of Medicine And Dentistry Of New Jersey |
Novel carbamates and ureas
|
|
US6451998B1
(en)
|
1999-10-18 |
2002-09-17 |
Agilent Technologies, Inc. |
Capping and de-capping during oligonucleotide synthesis
|
|
AU2622101A
(en)
*
|
1999-11-02 |
2001-05-14 |
Celine Hu |
Molecular microarrays and methods for production and use thereof
|
|
US6875619B2
(en)
|
1999-11-12 |
2005-04-05 |
Motorola, Inc. |
Microfluidic devices comprising biochannels
|
|
US6361958B1
(en)
|
1999-11-12 |
2002-03-26 |
Motorola, Inc. |
Biochannel assay for hybridization with biomaterial
|
|
WO2001036442A1
(en)
*
|
1999-11-17 |
2001-05-25 |
Jiuping Ji |
Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
|
|
US6716994B1
(en)
*
|
2000-01-04 |
2004-04-06 |
Applera Corporation |
Mobility-Modifying Cyanine Dyes
|
|
WO2001061054A2
(en)
|
2000-02-18 |
2001-08-23 |
Board Of Trustees Of The Leland Stanford Junior University |
Apparatus and methods for parallel processing of micro-volume liquid reactions
|
|
US20020151040A1
(en)
|
2000-02-18 |
2002-10-17 |
Matthew O' Keefe |
Apparatus and methods for parallel processing of microvolume liquid reactions
|
|
US7019129B1
(en)
|
2000-05-09 |
2006-03-28 |
Biosearch Technologies, Inc. |
Dark quenchers for donor-acceptor energy transfer
|
|
EP1313880A2
(de)
*
|
2000-05-30 |
2003-05-28 |
PE Corporation (NY) |
Methoden zur detektion gewünschter nukleinsäuren mittels kombinierter ligation und amplifizierung
|
|
US6887664B2
(en)
|
2000-06-06 |
2005-05-03 |
Applera Corporation |
Asynchronous primed PCR
|
|
AU2001268291A1
(en)
|
2000-06-07 |
2001-12-17 |
Li-Cor, Inc. |
Charge-switch nucleotides
|
|
US6869764B2
(en)
|
2000-06-07 |
2005-03-22 |
L--Cor, Inc. |
Nucleic acid sequencing using charge-switch nucleotides
|
|
US6936702B2
(en)
*
|
2000-06-07 |
2005-08-30 |
Li-Cor, Inc. |
Charge-switch nucleotides
|
|
EP1176151B1
(de)
|
2000-07-28 |
2014-08-20 |
Agilent Technologies, Inc. |
Synthese von Polynukleotiden unter Gebrauch von kombinierter Oxidations- und Entschützungschemie
|
|
DE60138916D1
(de)
|
2000-09-26 |
2009-07-16 |
Boston Probes Inc |
Sonden, sondensätzen,verfahren und kits zur nachweis, identifizierung und/oder die zählung von bakterien
|
|
CA2425663C
(en)
*
|
2000-10-11 |
2009-12-29 |
Applera Corporation |
Fluorescent nucleobase conjugates having anionic linkers
|
|
US6693187B1
(en)
*
|
2000-10-17 |
2004-02-17 |
Lievre Cornu Llc |
Phosphinoamidite carboxlates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge
|
|
EP1337542A2
(de)
*
|
2000-11-09 |
2003-08-27 |
Invitrogen Corporation |
Verfahren zum entfernen eines unversellen linkers aus einem oligonukleotid
|
|
WO2002043771A2
(en)
|
2000-12-01 |
2002-06-06 |
Cell Works Inc. |
Conjugates of glycosylated/galactosylated peptide
|
|
US6794141B2
(en)
|
2000-12-22 |
2004-09-21 |
Arcturus Bioscience, Inc. |
Nucleic acid amplification
|
|
US6825338B2
(en)
|
2001-03-30 |
2004-11-30 |
Isis Pharmaceuticals, Inc. |
Labeled oligonucleotides, methods for making same, and compounds useful therefor
|
|
ATE541937T1
(de)
*
|
2001-04-06 |
2012-02-15 |
Univ Chicago |
Chemotherapeutische einleitung der egr-1-promoter-aktivität in gentherapie
|
|
US20040242523A1
(en)
*
|
2003-03-06 |
2004-12-02 |
Ana-Farber Cancer Institue And The Univiersity Of Chicago |
Chemo-inducible cancer gene therapy
|
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
|
WO2002083922A2
(en)
*
|
2001-04-11 |
2002-10-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Modified random primers for probe labeling
|
|
US20030170675A1
(en)
*
|
2001-04-11 |
2003-09-11 |
The Gov't Of The U.S Of America As Represented By The Secretary Of The Dept. Of Health & Human Serv. |
Methods of manipulating nucleic acids
|
|
CA2381367A1
(en)
|
2001-04-12 |
2002-10-12 |
Hironori Komatsu |
Method for purifying 5'-protected 2'-deoxypurine nucleosides
|
|
US6867050B2
(en)
*
|
2001-05-16 |
2005-03-15 |
Academia Sinica |
Apparatus and methods for chemical synthesis
|
|
US20050009101A1
(en)
*
|
2001-05-17 |
2005-01-13 |
Motorola, Inc. |
Microfluidic devices comprising biochannels
|
|
WO2002095356A2
(en)
|
2001-05-21 |
2002-11-28 |
Aclara Biosciences, Inc. |
Methods and compositions for analyzing proteins
|
|
EP2070939B1
(de)
|
2001-05-25 |
2014-04-02 |
Duke University |
Modulatoren von pharmakologischen Wirkstoffen
|
|
EP1903054A3
(de)
|
2001-06-05 |
2008-07-23 |
CureVac GmbH |
Stabilisierte mRNA mit erhöhtem G/C-Gehalt und optimierter Codon Usage für die Gentherapie
|
|
US7118907B2
(en)
*
|
2001-06-06 |
2006-10-10 |
Li-Cor, Inc. |
Single molecule detection systems and methods
|
|
EP1412749A4
(de)
*
|
2001-06-28 |
2006-12-13 |
Ia Inc |
Faseroptisches sensorarray
|
|
US7153954B2
(en)
|
2001-07-12 |
2006-12-26 |
Santaris Pharma A/S |
Method for preparation of LNA phosphoramidites
|
|
DE60230927D1
(de)
|
2001-07-16 |
2009-03-05 |
Caprotec Bioanalytics Gmbh |
Fangverbindungen, ihre entnahme und verfahren zur analysierung des proteoms und von komplexen zusammensetzungen
|
|
US6822088B2
(en)
|
2001-07-17 |
2004-11-23 |
Isis Pharmaceuticals, Inc. |
Synthesis of oligonucleotides on solid support
|
|
US20050042629A1
(en)
|
2002-09-13 |
2005-02-24 |
Applera Corporation |
Thermus scotoductus nucleic acid polymerases
|
|
AU2002346498A1
(en)
|
2001-11-30 |
2003-06-17 |
Applera Corporation |
Thermus brockianus nucleic acid polymerases
|
|
WO2003048179A2
(en)
*
|
2001-12-03 |
2003-06-12 |
The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services |
Thermolabile hydroxyl protecting groups and methods of use
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
US7255874B1
(en)
|
2001-12-21 |
2007-08-14 |
Closure Medical Corporation |
Biocompatible polymers and adhesives: compositions, methods of making and uses related thereto
|
|
GB0200526D0
(en)
*
|
2002-01-11 |
2002-02-27 |
Science And Technology The |
Methods
|
|
WO2003062452A2
(en)
*
|
2002-01-23 |
2003-07-31 |
Proligo, Llc |
Methods for the integrated synthesis and purification of oligonucleotides
|
|
EP3415625A1
(de)
|
2002-02-01 |
2018-12-19 |
Life Technologies Corporation |
Doppelsträngige oligonukleotide
|
|
WO2003064621A2
(en)
|
2002-02-01 |
2003-08-07 |
Ambion, Inc. |
HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
|
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
|
ATE421088T1
(de)
*
|
2002-03-11 |
2009-01-15 |
Caprotec Bioanalytics Gmbh |
Verbindungen und verfahren für die analyse des proteoms
|
|
EP1485503A4
(de)
*
|
2002-03-15 |
2005-12-28 |
Arcturus Bioscience Inc |
Verbesserte nukleinsäureamplifikation
|
|
US7169916B2
(en)
*
|
2002-04-01 |
2007-01-30 |
Isis Pharmaceuticals, Inc. |
Chloral-free DCA in oligonucleotide synthesis
|
|
CN101078718A
(zh)
|
2002-05-08 |
2007-11-28 |
松下电器产业株式会社 |
含生物分子珠粒的管和使用它的分析装置
|
|
WO2003102216A2
(en)
*
|
2002-05-31 |
2003-12-11 |
Diversa Corporation |
Multiplexed systems for nucleic acid sequencing
|
|
CN100424091C
(zh)
|
2002-06-05 |
2008-10-08 |
三井化学株式会社 |
保护化2’-脱氧胞苷类的精制法
|
|
US20040248094A1
(en)
*
|
2002-06-12 |
2004-12-09 |
Ford Lance P. |
Methods and compositions relating to labeled RNA molecules that reduce gene expression
|
|
DE10229872A1
(de)
*
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
|
EP1386925A1
(de)
*
|
2002-07-31 |
2004-02-04 |
Girindus AG |
Verfahren zur Herstellung von Oligonukleotiden
|
|
US8277753B2
(en)
|
2002-08-23 |
2012-10-02 |
Life Technologies Corporation |
Microfluidic transfer pin
|
|
EP1575990B1
(de)
*
|
2002-09-08 |
2009-11-18 |
Applera Corporation |
Festphasengebundene PNA-Dimere und deren Synthese
|
|
US20040235005A1
(en)
*
|
2002-10-23 |
2004-11-25 |
Ernest Friedlander |
Methods and composition for detecting targets
|
|
US7030230B2
(en)
|
2002-10-25 |
2006-04-18 |
Isis Pharmaceuticals, Inc. |
Process of purifying phosphoramidites
|
|
US9150605B2
(en)
|
2002-11-05 |
2015-10-06 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
|
|
WO2004043979A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Pharmaceuticals, Inc. |
Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
US9150606B2
(en)
|
2002-11-05 |
2015-10-06 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
|
|
CN1723216A
(zh)
*
|
2002-12-09 |
2006-01-18 |
三井化学株式会社 |
亚磷酰胺的制造方法
|
|
GB0229423D0
(en)
*
|
2002-12-18 |
2003-01-22 |
Avecia Ltd |
Process
|
|
WO2004074818A2
(en)
|
2002-12-20 |
2004-09-02 |
Biotrove, Inc. |
Assay apparatus and method using microfluidic arrays
|
|
US7615629B2
(en)
*
|
2002-12-31 |
2009-11-10 |
Sigma-Aldrich Co. |
Methods and compositions for the tandem synthesis of two or more oligonucleotides on the same solid support
|
|
DE602004030212D1
(de)
*
|
2003-01-16 |
2011-01-05 |
Caprotec Bioanalytics Gmbh |
Verfahren zur identifizierung von auf arzneimittel nicht-zielgerichteten proteinen
|
|
US7002006B2
(en)
*
|
2003-02-12 |
2006-02-21 |
Isis Pharmaceuticals, Inc. |
Protection of nucleosides
|
|
JP3936300B2
(ja)
*
|
2003-02-28 |
2007-06-27 |
独立行政法人科学技術振興機構 |
新規なグアノシン誘導体及びその用途
|
|
WO2004087884A2
(en)
|
2003-03-27 |
2004-10-14 |
Ptc Therapeutics, Inc |
TARGETING ENZYMES OF THE tRNA SPLICING PATHWAY FOR IDENTIFICATION OF ANTI-FUNGAL AND/OR ANTI-PROLIFERATIVE MOLECULES
|
|
JP4634371B2
(ja)
|
2003-03-27 |
2011-02-16 |
ピーティーシー セラピューティクス，インコーポレーテッド |
ｔＲＮＡスプライシングエンドヌクレアーゼに標的化する化合物の同定方法、および該化合物の抗増殖剤としての使用
|
|
US7745116B2
(en)
*
|
2003-04-08 |
2010-06-29 |
Pacific Biosciences Of California, Inc. |
Composition and method for nucleic acid sequencing
|
|
US20070179100A1
(en)
*
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
|
WO2004101582A2
(en)
*
|
2003-05-09 |
2004-11-25 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Thermolabile hydroxyl protecting groups and methods of use
|
|
US7276599B2
(en)
|
2003-06-02 |
2007-10-02 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide synthesis with alternative solvents
|
|
US20050239089A1
(en)
*
|
2003-06-06 |
2005-10-27 |
Johnson Martin D |
Mobility cassettes
|
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
EP1662863A4
(de)
*
|
2003-09-18 |
2009-01-28 |
Mayo Foundation |
Transgene nichthumane tieg-tiere
|
|
JP5379347B2
(ja)
|
2003-09-18 |
2013-12-25 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
４’−チオヌクレオシドおよびオリゴマー化合物
|
|
EP2708541B1
(de)
|
2003-11-13 |
2015-01-28 |
Isis Pharmaceuticals, Inc. |
5,6-Dihydroxy-Isoindol-Derivate als Linker für Oligomer-Festphasensynthese
|
|
DE602004030041D1
(de)
|
2003-12-22 |
2010-12-23 |
Univ Pennsylvania |
Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
|
|
US20050191344A1
(en)
*
|
2004-01-15 |
2005-09-01 |
Samuel Zalipsky |
Liposome composition for delivery of therapeutic agents
|
|
US7691316B2
(en)
*
|
2004-02-12 |
2010-04-06 |
Chemistry & Technology For Genes, Inc. |
Devices and methods for the synthesis of nucleic acids
|
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
|
CA2559171A1
(en)
|
2004-03-12 |
2005-09-29 |
Biotrove, Inc. |
Nanoliter array loading
|
|
KR101185050B1
(ko)
|
2004-04-22 |
2012-10-04 |
레가도 바이오사이언스, 인코포레이티드 |
응고 인자의 개선된 모듈레이터
|
|
JP4592060B2
(ja)
*
|
2004-04-26 |
2010-12-01 |
キヤノン株式会社 |
Ｐｃｒ増幅反応装置、ならびに、該装置を利用するｐｃｒ増幅反応方法
|
|
IL162276A0
(en)
*
|
2004-06-01 |
2005-11-20 |
Hadasit Med Res Service |
Nucleic acid molecules as heparanase potent inhibitors, compositions and methods of use thereof
|
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
|
US20090048192A1
(en)
*
|
2004-06-03 |
2009-02-19 |
Isis Pharmaceuticals, Inc. |
Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation
|
|
US12070731B2
(en)
|
2004-08-04 |
2024-08-27 |
Life Technologies Corporation |
Methods and systems for aligning dispensing arrays with microfluidic sample arrays
|
|
US20060105453A1
(en)
|
2004-09-09 |
2006-05-18 |
Brenan Colin J |
Coating process for microfluidic sample arrays
|
|
US7427675B2
(en)
|
2004-08-23 |
2008-09-23 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for the characterization of oligonucleotides
|
|
DE102004042546A1
(de)
*
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
|
AU2005287078A1
(en)
|
2004-09-16 |
2006-03-30 |
Applied Biosystems, Llc. |
Fluorescent dye compounds, conjugates and uses thereof
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
ES2579805T3
(es)
|
2004-09-23 |
2016-08-16 |
Genentech, Inc. |
Anticuerpos y conjugados modificados por ingeniería genética con cisteína
|
|
WO2006065751A2
(en)
*
|
2004-12-13 |
2006-06-22 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
|
US20060142228A1
(en)
|
2004-12-23 |
2006-06-29 |
Ambion, Inc. |
Methods and compositions concerning siRNA's as mediators of RNA interference
|
|
JP2008527979A
(ja)
*
|
2005-01-12 |
2008-07-31 |
アプレラ コーポレイション |
核酸の選択的増幅のための組成物、方法およびキット
|
|
US7608433B2
(en)
|
2005-02-09 |
2009-10-27 |
Idexx Laboratories |
Method of detection of classical swine fever
|
|
EP2505591A1
(de)
|
2005-02-11 |
2012-10-03 |
Memorial Sloan-Kettering Cancer Center |
Verfahren und Zusammensetzungen zur Detektion eines arzneimittelresistenten EGFR-Mutanten
|
|
DE102005023170A1
(de)
|
2005-05-19 |
2006-11-23 |
Curevac Gmbh |
Optimierte Formulierung für mRNA
|
|
WO2006127009A1
(en)
|
2005-05-26 |
2006-11-30 |
Eragen Biosciences, Inc. |
Reagent for the improved synthesis of isoguanosine-containing oligonucleotides
|
|
JP2009501024A
(ja)
*
|
2005-07-12 |
2009-01-15 |
テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション |
癌の診断及び治療における遺伝的及びエピジェネティックな変化
|
|
US7892795B2
(en)
|
2005-08-02 |
2011-02-22 |
Focus Diagnostics, Inc. |
Methods and compositions for detecting BK virus
|
|
US20070202515A1
(en)
*
|
2005-10-12 |
2007-08-30 |
Pathologica, Llc. |
Promac signature application
|
|
EP1949152A4
(de)
*
|
2005-11-14 |
2014-02-05 |
Bayer Ip Gmbh |
Planare wellenleiter-erkennungschips und kammer zur ausführung von multiplex-pcr-tests
|
|
US7579459B2
(en)
*
|
2005-12-12 |
2009-08-25 |
Ngo Nam Q |
Activator bound solid supports for nucleic acid synthesis via the phosphoramidite approach
|
|
US7569686B1
(en)
|
2006-01-27 |
2009-08-04 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for synthesis of bicyclic nucleic acid analogs
|
|
ES2351674T3
(es)
|
2006-01-27 |
2011-02-09 |
Isis Pharmaceuticals, Inc. |
Análogos de ácidos nucleicos bicíclicos modificados en la posición 6.
|
|
EP2360281B1
(de)
|
2006-02-13 |
2013-07-03 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Primer und Sonden für den Nachweis und die Unterscheidung von Typen und Subtypen des Influenzavirus
|
|
AU2007245043A1
(en)
*
|
2006-03-24 |
2007-11-08 |
Archemix Corp. |
Solid support reagents for synthesis
|
|
DK2021472T3
(da)
|
2006-05-05 |
2011-09-19 |
Isis Pharmaceuticals Inc |
Forbindelser og fremgangsmåder til modulering af genekspression
|
|
CA2651453C
(en)
|
2006-05-11 |
2014-10-14 |
Isis Pharmaceuticals, Inc. |
5'-modified bicyclic nucleic acid analogs
|
|
US7666854B2
(en)
|
2006-05-11 |
2010-02-23 |
Isis Pharmaceuticals, Inc. |
Bis-modified bicyclic nucleic acid analogs
|
|
US20080009007A1
(en)
*
|
2006-06-16 |
2008-01-10 |
Pacific Biosciences Of California, Inc. |
Controlled initiation of primer extension
|
|
CA2657576C
(en)
|
2006-07-14 |
2023-10-31 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use thereof
|
|
JP2010507361A
(ja)
|
2006-07-31 |
2010-03-11 |
キュアバック ゲーエムベーハー |
具体的には免疫刺激剤／アジュバントとしての、一般式（Ｉ）：ＧｌＸｍＧｎ、または一般式（ＩＩ）：ＣｌＸｍＣｎで表される核酸
|
|
DE102006035618A1
(de)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
|
|
US8138330B2
(en)
*
|
2006-09-11 |
2012-03-20 |
Sigma-Aldrich Co. Llc |
Process for the synthesis of oligonucleotides
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
US7947447B2
(en)
|
2007-01-16 |
2011-05-24 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
|
KR101625363B1
(ko)
|
2007-05-10 |
2016-05-30 |
애질런트 테크놀로지스, 인크. |
Ｒｎａ 합성을 위한 티오카본-보호기
|
|
CA2688061A1
(en)
*
|
2007-05-23 |
2008-12-04 |
Mannkind Corporation |
Multicistronic vectors and methods for their design
|
|
EP2170917B1
(de)
|
2007-05-30 |
2012-06-27 |
Isis Pharmaceuticals, Inc. |
Über n-substituiertes aminomethylen verbrückte, bicyclische nukleinsäureanaloga
|
|
EP2173760B2
(de)
|
2007-06-08 |
2015-11-04 |
Isis Pharmaceuticals, Inc. |
Carbozyklische bizyklische nukleinsäureanaloga
|
|
WO2008157696A2
(en)
|
2007-06-19 |
2008-12-24 |
Stratos Genomics Inc. |
High throughput nucleic acid sequencing by expansion
|
|
EP2176280B2
(de)
|
2007-07-05 |
2015-06-24 |
Isis Pharmaceuticals, Inc. |
6-disubstituierte bizyklische nukleinsäureanaloga
|
|
US8404830B2
(en)
*
|
2007-07-17 |
2013-03-26 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
|
WO2009023855A2
(en)
|
2007-08-15 |
2009-02-19 |
Isis Pharmaceuticals, Inc. |
Tetrahydropyran nucleic acid analogs
|
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
|
CN101849008A
(zh)
|
2007-09-19 |
2010-09-29 |
应用生物系统有限公司 |
用于减少RNAi中的脱靶表型效应的siRNA的不依赖于序列的修饰形式和其稳定形式
|
|
EP3222290A1
(de)
|
2007-10-09 |
2017-09-27 |
CureVac AG |
Zusammensetzung zur behandlung von prostatakrebs
|
|
WO2009046738A1
(en)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
|
|
US7829735B2
(en)
*
|
2007-10-26 |
2010-11-09 |
Northwestern University |
Universal phosphoramidite for preparation of modified biomolecules and surfaces
|
|
WO2009061894A1
(en)
*
|
2007-11-06 |
2009-05-14 |
Pharmaessentia Corporation |
Novel synthesis of beta-nucleosides
|
|
CN101932707B
(zh)
|
2008-01-31 |
2013-08-21 |
库瑞瓦格有限责任公司 |
作为免疫刺激剂/佐剂的式(I)(NuGlXmGnNv)a的核酸及其衍生物
|
|
WO2009100320A2
(en)
|
2008-02-07 |
2009-08-13 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexitol nucleic acid analogs
|
|
EP2247729B1
(de)
|
2008-02-11 |
2019-05-01 |
Phio Pharmaceuticals Corp. |
Modifizierte rnai-polynukleotide und verwendungen davon
|
|
US8426378B2
(en)
|
2008-03-21 |
2013-04-23 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds comprising tricyclic nucelosides and methods for their use
|
|
WO2009124238A1
(en)
|
2008-04-04 |
2009-10-08 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds comprising neutrally linked terminal bicyclic nucleosides
|
|
US8273534B2
(en)
|
2008-05-14 |
2012-09-25 |
Genomic Health, Inc. |
Predictors of patient response to treatment with EGF receptor inhibitors
|
|
WO2010005693A1
(en)
*
|
2008-06-23 |
2010-01-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclized ngr peptide compounds, compositions, and methods of their use
|
|
JP5438922B2
(ja)
*
|
2008-06-25 |
2014-03-12 |
日東電工株式会社 |
核酸の製造方法
|
|
WO2010008582A2
(en)
|
2008-07-18 |
2010-01-21 |
Rxi Pharmaceuticals Corporation |
Phagocytic cell drug delivery system
|
|
EP2340309A2
(de)
|
2008-09-22 |
2011-07-06 |
Rxi Pharmaceuticals Corporation |
Neutrale nanotransporter
|
|
EP3067359A1
(de)
|
2008-09-23 |
2016-09-14 |
Scott G. Petersen |
Selbstfreisetzende biolabile phosphatgeschützte pro-oligos für therapeutika auf oligonukleotidbasis und vermittlung von rna-interferenz
|
|
EP2361256B1
(de)
|
2008-09-24 |
2013-04-10 |
Isis Pharmaceuticals, Inc. |
Cyclohexenylverbindungen als nukleinsäureanaloga
|
|
US8501805B2
(en)
|
2008-09-24 |
2013-08-06 |
Isis Pharmaceuticals, Inc. |
Substituted alpha-L-bicyclic nucleosides
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
EP2379084B1
(de)
|
2008-10-15 |
2017-11-22 |
Ionis Pharmaceuticals, Inc. |
Modulation der expression von faktor 11
|
|
CA2741294C
(en)
|
2008-10-24 |
2018-04-24 |
Isis Pharmaceuticals, Inc. |
5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
|
|
WO2010048585A2
(en)
|
2008-10-24 |
2010-04-29 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
|
US9074211B2
(en)
|
2008-11-19 |
2015-07-07 |
Rxi Pharmaceuticals Corporation |
Inhibition of MAP4K4 through RNAI
|
|
SG171914A1
(en)
|
2008-12-02 |
2011-07-28 |
Chiralgen Ltd |
Method for the synthesis of phosphorus atom modified nucleic acids
|
|
US9493774B2
(en)
|
2009-01-05 |
2016-11-15 |
Rxi Pharmaceuticals Corporation |
Inhibition of PCSK9 through RNAi
|
|
NZ594155A
(en)
|
2009-01-21 |
2013-02-22 |
Vertex Pharma |
Methods for amplifying hepatitis c virus nucleic acids
|
|
WO2010090762A1
(en)
|
2009-02-04 |
2010-08-12 |
Rxi Pharmaceuticals Corporation |
Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
|
US8536320B2
(en)
|
2009-02-06 |
2013-09-17 |
Isis Pharmaceuticals, Inc. |
Tetrahydropyran nucleic acid analogs
|
|
US8835117B2
(en)
|
2009-05-29 |
2014-09-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acids for detection and discrimination of genotypes of Chlamydophila psittaci
|
|
EP2451461A4
(de)
|
2009-07-06 |
2013-05-29 |
Ontorii Inc |
Neuartige nukleinsäure-prodrugs und verwendungsverfahren dafür
|
|
EP2278334A1
(de)
|
2009-07-22 |
2011-01-26 |
Etablissement Francais du Sang |
Membranbasierte Mikroarray-Vorrichtung zur Erkennung eines hohen Multianalyt-Durchlaufs
|
|
US9012421B2
(en)
|
2009-08-06 |
2015-04-21 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexose nucleic acid analogs
|
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
|
RU2016105962A
(ru)
|
2009-12-04 |
2018-11-23 |
Дженентек, Инк. |
Мультиспецифические антитела, аналоги антител, композиции и способы
|
|
WO2011069528A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Lyophilization of nucleic acids in lactate-containing solutions
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
WO2011085102A1
(en)
|
2010-01-11 |
2011-07-14 |
Isis Pharmaceuticals, Inc. |
Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
WO2011094580A2
(en)
|
2010-01-28 |
2011-08-04 |
Alnylam Pharmaceuticals, Inc. |
Chelated copper for use in the preparation of conjugated oligonucleotides
|
|
US10113206B2
(en)
|
2010-02-24 |
2018-10-30 |
Grifols Therapeutics Inc. |
Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
|
|
WO2011115818A1
(en)
|
2010-03-17 |
2011-09-22 |
Isis Pharmaceuticals, Inc. |
5'-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
BR112012024049A2
(pt)
|
2010-03-24 |
2017-03-01 |
Rxi Pharmaceuticals Corp |
interferência de rna em indicações dérmicas e fibróticas
|
|
CN106074591B
(zh)
|
2010-03-24 |
2020-01-14 |
菲奥医药公司 |
眼部症候中的rna干扰
|
|
EP2550000A4
(de)
|
2010-03-24 |
2014-03-26 |
Advirna Inc |
Selbstfreisetzende rnai-verbindungen von reduzierter grösse
|
|
AU2011240774B2
(en)
|
2010-04-12 |
2014-04-10 |
Otsuka Pharmaceutical Co., Ltd. |
Aptamers to beta-NGF and their use in treating beta-NGF mediated diseases and disorders
|
|
WO2011139721A1
(en)
|
2010-04-27 |
2011-11-10 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use thereof
|
|
EP3091027B1
(de)
|
2010-04-28 |
2018-01-17 |
Ionis Pharmaceuticals, Inc. |
5'-modifizierte nukleoside und daraus hergestellte oligomere verbindungen
|
|
US9156873B2
(en)
|
2010-04-28 |
2015-10-13 |
Isis Pharmaceuticals, Inc. |
Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefrom
|
|
EP2601204B1
(de)
|
2010-04-28 |
2016-09-07 |
Ionis Pharmaceuticals, Inc. |
Modifizierte nukleoside und daraus hergestellte oligomere verbindungen
|
|
WO2011156278A1
(en)
|
2010-06-07 |
2011-12-15 |
Isis Pharmaceuticals, Inc. |
Bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
SG185428A1
(en)
|
2010-06-08 |
2012-12-28 |
Genentech Inc |
Cysteine engineered antibodies and conjugates
|
|
WO2011156202A1
(en)
|
2010-06-08 |
2011-12-15 |
Isis Pharmaceuticals, Inc. |
Substituted 2 '-amino and 2 '-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
US8968746B2
(en)
|
2010-07-30 |
2015-03-03 |
Curevac Gmbh |
Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DK2620428T3
(da)
|
2010-09-24 |
2019-07-01 |
Wave Life Sciences Ltd |
Asymmetrisk hjælpegruppe
|
|
ES3005233T3
(en)
|
2010-10-01 |
2025-03-14 |
Modernatx Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
WO2012068405A2
(en)
|
2010-11-17 |
2012-05-24 |
Isis Pharmaceuticals, Inc. |
Modulation of alpha synuclein expression
|
|
AR084358A1
(es)
|
2010-12-27 |
2013-05-08 |
Lilly Co Eli |
Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
|
|
EP2658570B1
(de)
|
2010-12-27 |
2018-11-28 |
Elanco US Inc. |
Impfstoffzusammensetzung gegen virus der viralen rinderdiarrhoe und verwendung
|
|
UY33854A
(es)
|
2010-12-30 |
2012-07-31 |
Dow Agrosciences Llc |
Moléculas de ácido nucleico que se dirigen a la subunidad c de la atpasa vacuolar y confieren resistencia a las plagas de coleópteros
|
|
AP2013007016A0
(en)
|
2010-12-30 |
2013-07-31 |
Dow Agrosciences Llc |
Nucleic acid molecules that confer resistance to colepteran pests
|
|
BRPI1107329A2
(pt)
|
2010-12-30 |
2019-11-19 |
Dow Agrosciences Llc |
moléculas de ácido nucléico que direcionadas à subunidade h de atpase vacuolar que conferem resistência a pragas de coleópteros, vetor de transformação de planta, célula transformada, bem como métodos para controlar uma população de praga de coleóptero, controlar uma infestação pela dita praga, melhorar o rendimento de uma safra e para produzir uma célula transgênica
|
|
EP2658976A4
(de)
|
2010-12-30 |
2014-10-22 |
Dow Agrosciences Llc |
Auf kleines rho1-gtp-bindendes protein abzielende und und resistenz gegenüber coleopteran-schädlingen verleihende nukleinsäuremoleküle
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
DK2714939T3
(en)
|
2011-05-24 |
2015-06-29 |
Elitech Holding Bv |
DETECTION OF METHICILLIN-RESISTENT STAPHYLOCOCCUS AUREUS
|
|
WO2012170347A1
(en)
|
2011-06-09 |
2012-12-13 |
Isis Pharmaceuticals, Inc. |
Bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
AU2012271672B2
(en)
|
2011-06-15 |
2016-02-18 |
Grifols Therapeutics Inc. |
Methods, compositions, and kits for determining Human Immunodeficiency Virus (HIV)
|
|
US9605019B2
(en)
|
2011-07-19 |
2017-03-28 |
Wave Life Sciences Ltd. |
Methods for the synthesis of functionalized nucleic acids
|
|
JP6182529B2
(ja)
|
2011-07-26 |
2017-08-16 |
エリテックグループ・ベスローテン・フェンノートシャップＥｌｉｔｅｃｈｇｒｏｕｐ Ｂ．Ｖ． |
副溝結合剤ホスホラミダイトおよび使用方法
|
|
WO2013036332A2
(en)
|
2011-09-07 |
2013-03-14 |
Grifols Therapeutics Inc. |
Methods, compositions, and kits for determining hepatitis a virus
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2763701B1
(de)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
|
WO2013090457A2
(en)
|
2011-12-12 |
2013-06-20 |
Oncoimmunin Inc. |
In vivo delivery of oligonucleotides
|
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
|
US9428813B2
(en)
|
2012-03-26 |
2016-08-30 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
DNA methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
EP2850092B1
(de)
|
2012-04-09 |
2017-03-01 |
Ionis Pharmaceuticals, Inc. |
Tricyclische nukleinsäureanaloga
|
|
WO2013154799A1
(en)
|
2012-04-09 |
2013-10-17 |
Isis Pharmaceuticals, Inc. |
Tricyclic nucleosides and oligomeric compounds prepared therefrom
|
|
ES2683707T3
(es)
|
2012-05-02 |
2018-09-27 |
Ibis Biosciences, Inc. |
Secuenciación de ADN
|
|
ES2833524T3
(es)
|
2012-05-02 |
2021-06-15 |
Ibis Biosciences Inc |
Secuenciación de ADN
|
|
EP2850086B1
(de)
|
2012-05-18 |
2023-07-05 |
Pacific Biosciences Of California, Inc. |
Heteroarylcyaninfarbstoffe
|
|
WO2013185069A1
(en)
|
2012-06-08 |
2013-12-12 |
Shire Human Genetic Therapies, Inc. |
Pulmonary delivery of mrna to non-lung target cells
|
|
JP6246121B2
(ja)
|
2012-07-13 |
2017-12-13 |
株式会社新日本科学 |
キラル核酸アジュバント
|
|
CN112007045B
(zh)
|
2012-07-13 |
2026-01-06 |
波涛生命科学有限公司 |
手性控制
|
|
DK2872485T3
(da)
|
2012-07-13 |
2021-03-08 |
Wave Life Sciences Ltd |
Asymmetrisk hjælpegruppe
|
|
US9403865B2
(en)
|
2012-08-15 |
2016-08-02 |
Ionis Pharmaceuticals, Inc. |
Method of preparing oligomeric compounds using modified capping protocols
|
|
EP2885313A4
(de)
|
2012-08-20 |
2016-03-09 |
Univ California |
Polynukleotide mit bioreversiblen gruppen
|
|
WO2014030066A2
(en)
|
2012-08-22 |
2014-02-27 |
Bernitz Mats Nilsson |
Methods for identifying nucleic acid sequences
|
|
US10294261B2
(en)
*
|
2012-09-04 |
2019-05-21 |
Kabushiki Kaisha Dnaform |
Compound, nucleic acid, labeling substance, and detection method
|
|
MY167603A
(en)
|
2012-10-04 |
2018-09-20 |
The Board Of Trustees Of Leland Stanford Junior Univ |
Method and reagents for detection, quantitation, and serotyping of dengue viruses
|
|
US9029335B2
(en)
|
2012-10-16 |
2015-05-12 |
Isis Pharmaceuticals, Inc. |
Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
DK2909339T3
(en)
|
2012-10-18 |
2018-08-13 |
Idexx Lab Inc |
Kits comprehensive controls for nucleic acid amplification
|
|
EP2909341A2
(de)
|
2012-10-18 |
2015-08-26 |
Oslo Universitetssykehus HF |
Biomarker für gebärmutterhalskrebs
|
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
|
US9701708B2
(en)
|
2013-01-31 |
2017-07-11 |
Ionis Pharmaceuticals, Inc. |
Method of preparing oligomeric compounds using modified coupling protocols
|
|
ES2882110T3
(es)
|
2013-03-14 |
2021-12-01 |
Translate Bio Inc |
Métodos y composiciones para administrar anticuerpos codificados con ARNm
|
|
ES2981185T3
(es)
|
2013-03-14 |
2024-10-07 |
Translate Bio Inc |
Métodos para la purificación de ARN mensajero
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
CA2921162A1
(en)
|
2013-05-01 |
2014-11-06 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
EP3004131B1
(de)
|
2013-06-05 |
2020-07-22 |
AM Chemicals Llc |
Phosphoramidit-bausteine für zuckerkonjugierte oligonukleotide
|
|
US9069358B2
(en)
|
2013-06-24 |
2015-06-30 |
Biolytic Lab Performance, Inc. |
System for controlling and optimizing reactions in solid phase synthesis of small molecules
|
|
TWI707038B
(zh)
|
2013-08-05 |
2020-10-11 |
美商扭轉生物科技有限公司 |
重新合成之基因庫
|
|
CA2915728A1
(en)
|
2013-08-21 |
2015-02-26 |
Thomas Kramps |
Respiratory syncytial virus (rsv) vaccine
|
|
EP3035955B1
(de)
|
2013-08-21 |
2019-09-11 |
CureVac AG |
Zusammensetzung und impfstoff zur behandlung von lungenkrebs
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
US11162096B2
(en)
|
2013-10-14 |
2021-11-02 |
Ionis Pharmaceuticals, Inc |
Methods for modulating expression of C9ORF72 antisense transcript
|
|
WO2015061246A1
(en)
|
2013-10-21 |
2015-04-30 |
Isis Pharmaceuticals, Inc. |
Method for solution phase detritylation of oligomeric compounds
|
|
MX2016005239A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
|
|
WO2015061467A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Lipid formulations for delivery of messenger rna
|
|
US11224642B2
(en)
|
2013-10-22 |
2022-01-18 |
Translate Bio, Inc. |
MRNA therapy for argininosuccinate synthetase deficiency
|
|
CA2928040A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Cns delivery of mrna and uses thereof
|
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
|
US10172916B2
(en)
|
2013-11-15 |
2019-01-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of treating heart failure with agonists of hypocretin receptor 2
|
|
SG10202006426QA
(en)
|
2013-11-21 |
2020-08-28 |
Somalogic Inc |
Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto
|
|
CN106061488B
(zh)
|
2013-12-02 |
2021-04-09 |
菲奥医药公司 |
癌症的免疫治疗
|
|
WO2015095750A1
(en)
|
2013-12-20 |
2015-06-25 |
Dow Agrosciences Llc |
Rnapii-140 nucleic acid molecules that confer resistance to coleopteran pests
|
|
BR102014031844A2
(pt)
|
2013-12-20 |
2015-10-06 |
Dow Agrosciences Llc |
ras oposto (rop) e moléculas de ácido nucleico relacionadas que conferem resistência a pragas de coleópteros e hemípteros
|
|
CN111304231A
(zh)
|
2013-12-30 |
2020-06-19 |
库瑞瓦格股份公司 |
人工核酸分子
|
|
EP3495486B1
(de)
|
2013-12-30 |
2020-12-16 |
CureVac AG |
Künstliche nukleinsäuremoleküle
|
|
WO2015101415A1
(en)
|
2013-12-30 |
2015-07-09 |
Curevac Gmbh |
Artificial nucleic acid molecules
|
|
EP3095461A4
(de)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chirales nukleinsäure-adjuvans mit immunitätsinduktionswirkung und immunitätsinduktionsaktivator
|
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
|
WO2015108048A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
|
KR102423317B1
(ko)
|
2014-01-16 |
2022-07-22 |
웨이브 라이프 사이언시스 리미티드 |
키랄 디자인
|
|
WO2015142910A1
(en)
|
2014-03-17 |
2015-09-24 |
Isis Pharmaceuticals, Inc. |
Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
|
|
WO2015143245A1
(en)
|
2014-03-19 |
2015-09-24 |
Isis Pharmaceuticals, Inc. |
Methods for modulating ataxin 2 expression
|
|
CN116970607A
(zh)
|
2014-03-19 |
2023-10-31 |
Ionis制药公司 |
用于调节共济失调蛋白2表达的组合物
|
|
PT3122878T
(pt)
|
2014-03-24 |
2019-02-01 |
Translate Bio Inc |
Terapia de arnm para o tratamento de doenças oculares
|
|
MY192634A
(en)
|
2014-04-01 |
2022-08-29 |
Biogen Ma Inc |
Compositions for modulating sod-1 expression
|
|
CA2936286A1
(en)
|
2014-04-01 |
2015-10-08 |
Curevac Ag |
Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
|
|
US10221416B2
(en)
|
2014-04-24 |
2019-03-05 |
Ionis Pharmaceuticals, Inc. |
Oligomeric compounds comprising alpha-beta-constrained nucleic acid
|
|
JP6571679B2
(ja)
|
2014-04-25 |
2019-09-04 |
トランスレイト バイオ， インコーポレイテッド |
メッセンジャーｒｎａの精製方法
|
|
WO2015168172A1
(en)
|
2014-04-28 |
2015-11-05 |
Isis Pharmaceuticals, Inc. |
Linkage modified oligomeric compounds
|
|
US11279934B2
(en)
|
2014-04-28 |
2022-03-22 |
Phio Pharmaceuticals Corp. |
Methods for treating cancer using nucleic acids targeting MDM2 or MYCN
|
|
EP3943500A1
(de)
|
2014-04-30 |
2022-01-26 |
Agilent Technologies, Inc. |
Phosphorschutzgruppen und verfahren zu ihrer herstellung und ihre verwendung
|
|
WO2015168514A1
(en)
|
2014-05-01 |
2015-11-05 |
Isis Pharmaceuticals, Inc. |
Method for synthesis of reactive conjugate clusters
|
|
US10280423B2
(en)
|
2014-05-01 |
2019-05-07 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating complement factor B expression
|
|
UY36113A
(es)
|
2014-05-07 |
2015-10-30 |
Dow Agrosciences Llc |
Moléculas de ácido nucleico dre4 que confieren resistencia a plagas de coleópteros
|
|
US10018617B2
(en)
|
2014-05-16 |
2018-07-10 |
Life Technologies Corporation |
Carbopyronone compounds useful as diagnostic adjuvants
|
|
US10022455B2
(en)
|
2014-05-30 |
2018-07-17 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
|
WO2015191303A2
(en)
|
2014-06-10 |
2015-12-17 |
Agilent Technologies, Inc. |
Protecting groups for "z nucleotide" and methods thereof
|
|
CA2952824C
(en)
|
2014-06-24 |
2023-02-21 |
Shire Human Genetic Therapies, Inc. |
Stereochemically enriched compositions for delivery of nucleic acids
|
|
CA2953265C
(en)
|
2014-07-02 |
2023-09-26 |
Shire Human Genetic Therapies, Inc. |
Encapsulation of messenger rna
|
|
US10093967B2
(en)
|
2014-08-12 |
2018-10-09 |
The Regents Of The University Of Michigan |
Detection of nucleic acids
|
|
KR102506169B1
(ko)
|
2014-09-05 |
2023-03-08 |
피오 파마슈티칼스 코프. |
Tyr 또는 mmp1을 표적화하는 핵산을 사용한 노화 및 피부 장애의 치료 방법
|
|
WO2016040748A1
(en)
|
2014-09-12 |
2016-03-17 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for detection of smn protein in a subject and treatment of a subject
|
|
TW201625688A
(zh)
|
2014-09-12 |
2016-07-16 |
建南德克公司 |
經半胱胺酸改造之抗體及接合物
|
|
US10308947B2
(en)
|
2014-10-17 |
2019-06-04 |
The Penn State Research Foundation |
Methods and compositions for multiplex RNA guided genome editing and other RNA technologies
|
|
MA56412A
(fr)
|
2014-12-05 |
2022-05-04 |
Translate Bio Inc |
Thérapie par l'arn messager pour le traitement des maladies articulaires
|
|
US11543411B2
(en)
|
2014-12-05 |
2023-01-03 |
Prelude Corporation |
DCIS recurrence and invasive breast cancer
|
|
EP3230468B1
(de)
|
2014-12-12 |
2020-09-16 |
ELITechGroup, Inc. |
Verfahren und kits zum nachweis von antibiotikaresistenten bakterien
|
|
ES2946969T3
(es)
|
2014-12-12 |
2023-07-28 |
CureVac SE |
Moléculas de ácido nucleico artificiales para una expresión proteica mejorada
|
|
EP3230467A1
(de)
|
2014-12-12 |
2017-10-18 |
ELITechGroup B.V. |
Verfahren und zusammensetzungen zum nachweis von antibiotikaresistenten bakterien
|
|
ES2811279T3
(es)
|
2014-12-22 |
2021-03-11 |
Fraunhofer Ges Forschung |
Moléculas de ácido nucleico de Nucampholin para controlar plagas de insectos coleópteros
|
|
JP6907116B2
(ja)
|
2014-12-30 |
2021-07-21 |
キュアバック アーゲー |
人工核酸分子
|
|
US9688707B2
(en)
|
2014-12-30 |
2017-06-27 |
Ionis Pharmaceuticals, Inc. |
Bicyclic morpholino compounds and oligomeric compounds prepared therefrom
|
|
WO2016112132A1
(en)
|
2015-01-06 |
2016-07-14 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of c9orf72 antisense transcript
|
|
WO2016115490A1
(en)
|
2015-01-16 |
2016-07-21 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulation of dux4
|
|
WO2016126987A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Compositions and methods for synthetic gene assembly
|
|
WO2016126882A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
WO2016137923A1
(en)
|
2015-02-23 |
2016-09-01 |
Ionis Pharmaceuticals, Inc. |
Method for solution phase detritylation of oligomeric compounds
|
|
US11129844B2
(en)
|
2015-03-03 |
2021-09-28 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating MECP2 expression
|
|
EP3067424A1
(de)
|
2015-03-13 |
2016-09-14 |
Dow AgroSciences LLC |
Rna-polymerase-i1-nukleinsäuremoleküle zur kontrolle von insektenschädlingen
|
|
WO2016149508A1
(en)
|
2015-03-19 |
2016-09-22 |
Shire Human Genetic Therapies, Inc. |
Mrna therapy for pompe disease
|
|
WO2016167780A1
(en)
|
2015-04-16 |
2016-10-20 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of c9orf72 antisense transcript
|
|
US9981239B2
(en)
|
2015-04-21 |
2018-05-29 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
BR102016012010A2
(pt)
|
2015-05-29 |
2020-03-24 |
Dow Agrosciences Llc |
Molécula de ácido nucleico, de ácido ribonucleico (rna) e de ácido ribonucleico de filamento duplo (dsrna), usos de célula, planta e semente, produto primário, bem como métodos para controlar uma população de pragas coleópteras e/ou hemípteras, para melhorar o rendimento de uma cultura, e para produzir uma célula vegetal transgênica e uma planta transgênica
|
|
GB201511470D0
(en)
|
2015-06-30 |
2015-08-12 |
Cellcall Kft |
HPV detection method
|
|
US11001845B2
(en)
|
2015-07-06 |
2021-05-11 |
Phio Pharmaceuticals Corp. |
Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)
|
|
US10808247B2
(en)
|
2015-07-06 |
2020-10-20 |
Phio Pharmaceuticals Corp. |
Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
|
|
WO2017015575A1
(en)
|
2015-07-22 |
2017-01-26 |
Wave Life Sciences Ltd. |
Oligonucleotide compositions and methods thereof
|
|
WO2017024182A1
(en)
|
2015-08-04 |
2017-02-09 |
Duke University |
Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same
|
|
KR102645398B1
(ko)
|
2015-08-28 |
2024-03-07 |
큐어백 에스이 |
신규 인공 핵산 분자
|
|
KR20180050411A
(ko)
|
2015-09-18 |
2018-05-14 |
트위스트 바이오사이언스 코포레이션 |
올리고핵산 변이체 라이브러리 및 그의 합성
|
|
CN108698012A
(zh)
|
2015-09-22 |
2018-10-23 |
特韦斯特生物科学公司 |
用于核酸合成的柔性基底
|
|
US10533175B2
(en)
|
2015-09-25 |
2020-01-14 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating Ataxin 3 expression
|
|
CN109563509B
(zh)
|
2015-10-19 |
2022-08-09 |
菲奥医药公司 |
靶向长非编码rna的减小尺寸的自递送核酸化合物
|
|
WO2017081082A2
(en)
|
2015-11-09 |
2017-05-18 |
Curevac Ag |
Optimized nucleic acid molecules
|
|
WO2017095958A1
(en)
|
2015-12-01 |
2017-06-08 |
Twist Bioscience Corporation |
Functionalized surfaces and preparation thereof
|
|
US11058709B1
(en)
|
2015-12-04 |
2021-07-13 |
Ionis Pharmaceuticals, Inc. |
Methods of treating breast cancer
|
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
WO2017111137A1
(ja)
|
2015-12-22 |
2017-06-29 |
味の素株式会社 |
オリゴヌクレオチドの製造方法
|
|
CA3006015A1
(en)
|
2015-12-31 |
2017-07-06 |
Ionis Pharmaceuticals, Inc. |
Methods for reducing ataxin-2 expression
|
|
AU2017205462A1
(en)
|
2016-01-05 |
2018-06-07 |
Ionis Pharmaceuticals, Inc. |
Methods for reducing LRRK2 expression
|
|
EP3429690A4
(de)
|
2016-03-16 |
2019-10-23 |
Ionis Pharmaceuticals, Inc. |
Verfahren zur modulation von keap1
|
|
WO2017161168A1
(en)
|
2016-03-16 |
2017-09-21 |
Ionis Pharmaceuticals, Inc. |
Modulation of dyrk1b expression
|
|
KR102369898B1
(ko)
|
2016-04-08 |
2022-03-03 |
트랜슬레이트 바이오 인코포레이티드 |
다량체 코딩 핵산 및 그 용도
|
|
EP3443123B1
(de)
|
2016-04-11 |
2021-08-11 |
Board of Regents, The University of Texas System |
Verfahren und zusammensetzungen zum nachweis der affinität einzelner t-zellrezeptoren und sequenz
|
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
|
CN109312313A
(zh)
|
2016-06-13 |
2019-02-05 |
川斯勒佰尔公司 |
用于治疗鸟氨酸转氨甲酰酶缺乏症的信使rna疗法
|
|
CA3023514A1
(en)
|
2016-06-17 |
2017-12-21 |
Ionis Pharmaceuticals, Inc. |
Modulation of gys1 expression
|
|
EP3484908A4
(de)
|
2016-07-15 |
2020-04-08 |
AM Chemicals Llc |
Nicht-nukleosidische feste träger und phosphoramiditbausteine für die oligonukleotidsynthese
|
|
CN109963871A
(zh)
|
2016-08-05 |
2019-07-02 |
豪夫迈·罗氏有限公司 |
具有激动活性的多价及多表位抗体以及使用方法
|
|
WO2018035380A1
(en)
|
2016-08-17 |
2018-02-22 |
Solstice Biologics, Ltd. |
Polynucleotide constructs
|
|
US10907156B2
(en)
|
2016-08-19 |
2021-02-02 |
Fundación Para La Investigación Biomédica Del Hospital Univ. Ramón Y Cajal |
MiR-127 agents for use in the treatment of renal fibrosis
|
|
KR102212257B1
(ko)
|
2016-08-22 |
2021-02-04 |
트위스트 바이오사이언스 코포레이션 |
드 노보 합성된 핵산 라이브러리
|
|
WO2018057526A2
(en)
|
2016-09-21 |
2018-03-29 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
|
EP3515928B1
(de)
|
2016-09-23 |
2026-01-28 |
Duke University |
Unstrukturierte nichtrepititive polypeptide mit lcst-verhalten
|
|
KR20190065341A
(ko)
|
2016-10-06 |
2019-06-11 |
아이오니스 파마수티컬즈, 인코포레이티드 |
올리고머 화합물들의 접합 방법
|
|
JP7560946B2
(ja)
|
2016-11-10 |
2024-10-03 |
トランスレイト バイオ， インコーポレイテッド |
メッセンジャーｒｎａの皮下送達
|
|
JOP20190104A1
(ar)
|
2016-11-10 |
2019-05-07 |
Ionis Pharmaceuticals Inc |
مركبات وطرق لتقليل التعبير عن atxn3
|
|
US10392620B2
(en)
|
2016-11-10 |
2019-08-27 |
Dow Agrosciences Llc |
Cytochrome B (CYTB) nucleic acid molecules that control pathogens
|
|
MA46762A
(fr)
|
2016-11-10 |
2019-09-18 |
Translate Bio Inc |
Procédé amélioré de préparation de nanoparticules lipidiques chargées d'arnm
|
|
MX2019005470A
(es)
|
2016-11-10 |
2019-11-21 |
Translate Bio Inc |
Formulación de nanopartículas lipídicas basadas en ice mejorada para el suministro de arnm.
|
|
US11033570B2
(en)
|
2016-12-02 |
2021-06-15 |
Cold Spring Harbor Laboratory |
Modulation of Lnc05 expression
|
|
EP3554514A4
(de)
|
2016-12-16 |
2020-08-05 |
Twist Bioscience Corporation |
Variante bibliotheken der immunologischen synapse und synthese davon
|
|
EP3342780A1
(de)
|
2016-12-30 |
2018-07-04 |
Dow AgroSciences LLC |
Nukleinsäuremoleküle mit prä-mrna-verarbeitungsfaktor 8 (prp8) zur kontrolle von insektenschädlingen
|
|
US11648200B2
(en)
|
2017-01-12 |
2023-05-16 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
|
CN110892485B
(zh)
|
2017-02-22 |
2024-03-22 |
特韦斯特生物科学公司 |
基于核酸的数据存储
|
|
CA3054321A1
(en)
|
2017-02-27 |
2018-08-30 |
Translate Bio, Inc. |
Methods for purification of messenger rna
|
|
ES2925083T3
(es)
|
2017-02-27 |
2022-10-13 |
Translate Bio Inc |
Métodos de purificación de ARN mensajero
|
|
WO2018165257A1
(en)
|
2017-03-07 |
2018-09-13 |
Translate Bio, Inc. |
Polyanionic delivery of nucleic acids
|
|
EP3592768B1
(de)
|
2017-03-08 |
2024-12-25 |
The Regents of The University of Michigan |
Analytnachweis
|
|
US11180756B2
(en)
|
2017-03-09 |
2021-11-23 |
Ionis Pharmaceuticals |
Morpholino modified oligomeric compounds
|
|
AU2018234629A1
(en)
|
2017-03-15 |
2019-10-17 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
|
JP7167059B2
(ja)
|
2017-04-19 |
2022-11-08 |
フィオ ファーマシューティカルズ コーポレーション |
核酸化合物の局所送達
|
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
|
MX2019013752A
(es)
|
2017-05-16 |
2020-07-20 |
Translate Bio Inc |
Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr optimizado en codones.
|
|
JP7169999B2
(ja)
|
2017-06-12 |
2022-11-11 |
ツイスト バイオサイエンス コーポレーション |
シームレス核酸アセンブリのための方法
|
|
EP3638716B1
(de)
|
2017-06-12 |
2022-01-05 |
Translate Bio, Inc. |
Poly(phosphoester) zur verabreichung von nukleinsäuren
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
EP3641834B1
(de)
|
2017-06-19 |
2023-10-04 |
Translate Bio, Inc. |
Messenger-rna-therapie zur behandlung von friedreich-ataxie
|
|
WO2019006455A1
(en)
|
2017-06-30 |
2019-01-03 |
Solstice Biologics, Ltd. |
AUXILIARIES OF CHIRAL PHOSPHORAMIDITIS AND METHODS OF USE THEREOF
|
|
EP3658168A4
(de)
|
2017-06-30 |
2021-07-14 |
Duke University |
Ordnung und unordnung als designprinzip für auf stimuli ansprechende biopolymernetzwerke
|
|
AU2018318231A1
(en)
|
2017-08-18 |
2020-02-13 |
Ionis Pharmaceuticals, Inc. |
Modulation of the notch signaling pathway for treatment of respiratory disorders
|
|
US10517889B2
(en)
|
2017-09-08 |
2019-12-31 |
Ionis Pharmaceuticals, Inc. |
Modulators of SMAD7 expression
|
|
AU2018328847A1
(en)
|
2017-09-11 |
2020-04-23 |
Twist Bioscience Corporation |
GPCR binding proteins and synthesis thereof
|
|
CA3075532A1
(en)
|
2017-09-15 |
2019-03-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Multiplex production and barcoding of genetically engineered cells
|
|
WO2019079769A1
(en)
|
2017-10-20 |
2019-04-25 |
Twist Bioscience Corporation |
HEATED NANOWELLS FOR THE SYNTHESIS OF POLYNUCLEOTIDES
|
|
TWI809004B
(zh)
|
2017-11-09 |
2023-07-21 |
美商Ionis製藥公司 |
用於降低snca表現之化合物及方法
|
|
US11167043B2
(en)
|
2017-12-20 |
2021-11-09 |
Translate Bio, Inc. |
Composition and methods for treatment of ornithine transcarbamylase deficiency
|
|
WO2019126641A2
(en)
|
2017-12-21 |
2019-06-27 |
Ionis Pharmaceuticals, Inc. |
Modulation of frataxin expression
|
|
EP4715681A2
(de)
|
2018-01-04 |
2026-03-25 |
Atlas Data Storage, Inc. |
Digitale informationsspeicherung auf dna-basis
|
|
US20200392510A1
(en)
|
2018-01-15 |
2020-12-17 |
Ionis Pharmaceuticals, Inc. |
Modulators of dnm2 expression
|
|
WO2019147954A1
(en)
|
2018-01-26 |
2019-08-01 |
Duke University |
Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
|
|
WO2019152802A1
(en)
|
2018-02-02 |
2019-08-08 |
Translate Bio, Inc. |
Cationic polymers
|
|
TWI840345B
(zh)
|
2018-03-02 |
2024-05-01 |
美商Ionis製藥公司 |
Irf4表現之調節劑
|
|
US11732260B2
(en)
|
2018-03-02 |
2023-08-22 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for the modulation of amyloid-β precursor protein
|
|
EP3768694A4
(de)
|
2018-03-22 |
2021-12-29 |
Ionis Pharmaceuticals, Inc. |
Verfahren zur modulierung der fmr1-expression
|
|
CA3094020A1
(en)
|
2018-04-11 |
2019-10-17 |
Ionis Pharmaceuticals, Inc. |
Modulators of ezh2 expression
|
|
CA3096682A1
(en)
|
2018-04-13 |
2019-10-17 |
Bristol-Myers Squibb Company |
Novel phosphorous (v)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (v) compounds
|
|
EP3788343B1
(de)
|
2018-04-30 |
2024-03-27 |
Duke University |
Auf stimuli reagierende plattform zur abgabe von auf peg-like-polymer basierendem arzneimittel
|
|
US11866788B2
(en)
|
2018-05-08 |
2024-01-09 |
Sanford Burnham Prebys Medical Discovery Institute |
Role of PVT1 in the diagnosis and treatment of MYC-driven cancer
|
|
SG11202010215TA
(en)
|
2018-05-09 |
2020-11-27 |
Ionis Pharmaceuticals Inc |
Compounds and methods for reducing atxn3 expression
|
|
JP7438135B2
(ja)
|
2018-05-09 |
2024-02-26 |
アイオーニス ファーマシューティカルズ， インコーポレーテッド |
Ｆｘｉの発現を低下させるための化合物及び方法
|
|
AU2019271132B2
(en)
|
2018-05-15 |
2026-02-05 |
Translate Bio, Inc. |
Subcutaneous delivery of messenger RNA
|
|
US11964051B2
(en)
|
2018-05-16 |
2024-04-23 |
Translate Bio, Inc. |
Ribose cationic lipids
|
|
IL278771B2
(en)
|
2018-05-18 |
2025-09-01 |
Twist Bioscience Corp |
Polynucleotides, reagents and methods for nucleic acid hybridization
|
|
AU2019275068B2
(en)
|
2018-05-24 |
2024-09-26 |
Translate Bio, Inc. |
Thioester cationic lipids
|
|
WO2019232095A1
(en)
|
2018-05-30 |
2019-12-05 |
Translate Bio, Inc. |
Vitamin cationic lipids
|
|
AU2019277355A1
(en)
|
2018-05-30 |
2020-12-17 |
Translate Bio, Inc. |
Phosphoester cationic lipids
|
|
AU2019277361B2
(en)
|
2018-05-30 |
2025-04-24 |
Translate Bio, Inc. |
Messenger RNA vaccines and uses thereof
|
|
US11547666B2
(en)
|
2018-05-30 |
2023-01-10 |
Translate Bio, Inc. |
Cationic lipids comprising a steroidal moiety
|
|
US11384376B2
(en)
|
2018-05-31 |
2022-07-12 |
Roche Molecular Systems, Inc. |
Reagents and methods for post-synthetic modification of nucleic acids
|
|
US11833168B2
(en)
|
2018-06-14 |
2023-12-05 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for increasing STMN2 expression
|
|
TWI833770B
(zh)
|
2018-06-27 |
2024-03-01 |
美商Ionis製藥公司 |
用於減少 lrrk2 表現之化合物及方法
|
|
JP7347830B2
(ja)
|
2018-06-29 |
2023-09-20 |
エバーハルト カール ウニヴェルジテート テュービンゲン |
Ｒｎａ編集のための人工核酸
|
|
EP3823725A4
(de)
|
2018-07-17 |
2023-05-10 |
Aronora, Inc. |
Verfahren zur sicheren reduzierung von thrombopoietin
|
|
KR20210056331A
(ko)
|
2018-07-23 |
2021-05-18 |
트랜슬레이트 바이오 인코포레이티드 |
전령 rna의 건조 분말 제형
|
|
CA3106986A1
(en)
|
2018-07-25 |
2020-01-30 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing atxn2 expression
|
|
US11649275B2
(en)
|
2018-08-02 |
2023-05-16 |
Duke University |
Dual agonist fusion proteins
|
|
CN118421617A
(zh)
|
2018-08-24 |
2024-08-02 |
川斯勒佰尔公司 |
用于纯化信使rna的方法
|
|
KR20210091120A
(ko)
|
2018-08-29 |
2021-07-21 |
트랜슬레이트 바이오 인코포레이티드 |
Mrna-로딩된 지질 나노입자를 제조하는 개선된 공정
|
|
WO2020051541A1
(en)
|
2018-09-07 |
2020-03-12 |
Duke University |
Nanoparticulate drug delivery systems
|
|
WO2020056338A1
(en)
|
2018-09-14 |
2020-03-19 |
Prelude Corporation |
Method of selection for treatment of subjects at risk of invasive breast cancer
|
|
US12564645B2
(en)
|
2018-09-14 |
2026-03-03 |
Translate Bio, Inc. |
Methods for treatment of methylmalonic acidemia
|
|
KR20210090634A
(ko)
|
2018-10-19 |
2021-07-20 |
트랜슬레이트 바이오 인코포레이티드 |
전령 rna의 무펌프 캡슐화
|
|
EP3877538A1
(de)
|
2018-11-08 |
2021-09-15 |
Translate Bio, Inc. |
Verfahren und zusammensetzungen zur aufreinigung von messenger-rna
|
|
KR102860605B1
(ko)
|
2018-11-09 |
2025-09-15 |
트랜슬레이트 바이오 인코포레이티드 |
에스테르, 티오에스테르, 이황화물, 및 무수물 모이어티가 삽입된 2,5-디옥소피페라진
|
|
AU2019374871B2
(en)
|
2018-11-09 |
2025-09-11 |
Translate Bio, Inc. |
PEG lipidoid compounds
|
|
WO2020097376A1
(en)
|
2018-11-09 |
2020-05-14 |
Translate Bio, Inc. |
Multi-peg lipid compounds
|
|
EP3876914A2
(de)
|
2018-11-09 |
2021-09-15 |
Translate Bio, Inc. |
Messenger-rna-therapie zur behandlung von augenerkrankungen
|
|
AU2019378763B2
(en)
|
2018-11-12 |
2025-06-26 |
Translate Bio, Inc. |
Methods for inducing immune tolerance
|
|
TW202028222A
(zh)
|
2018-11-14 |
2020-08-01 |
美商Ionis製藥公司 |
Foxp3表現之調節劑
|
|
EA202191342A1
(ru)
|
2018-11-15 |
2021-08-10 |
Айонис Фармасьютикалз, Инк. |
Модуляторы экспрессии irf5
|
|
EP3883917B1
(de)
|
2018-11-21 |
2024-01-24 |
Translate Bio, Inc. |
Kationische lipidverbindungen und deren zusammensetzungen zur verwendung bei der verabreichung von messenger-rna
|
|
US12281305B2
(en)
|
2018-11-21 |
2025-04-22 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing prion expression
|
|
EP3883592A1
(de)
|
2018-11-21 |
2021-09-29 |
Translate Bio, Inc. |
Behandlung von zystischer fibrose durch verabreichung von vernebelter mrna, die cftr codiert
|
|
WO2020139871A1
(en)
|
2018-12-26 |
2020-07-02 |
Twist Bioscience Corporation |
Highly accurate de novo polynucleotide synthesis
|
|
CN113412273B
(zh)
|
2019-01-07 |
2025-08-22 |
川斯勒佰尔公司 |
用于治疗原发性纤毛运动障碍的组合物和方法
|
|
MX2021008918A
(es)
|
2019-01-31 |
2021-08-24 |
Ionis Pharmaceuticals Inc |
Moduladores de expresion yap1.
|
|
JP2022520063A
(ja)
|
2019-02-08 |
2022-03-28 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
組み合わせ遺伝子修飾を有する操作された細胞の産生および追跡
|
|
AU2020227802A1
(en)
|
2019-02-26 |
2021-10-14 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for antibody optimization
|
|
WO2020176678A1
(en)
|
2019-02-26 |
2020-09-03 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for glp1 receptor
|
|
WO2020176771A1
(en)
|
2019-02-27 |
2020-09-03 |
Ionis Pharmaceuticals, Inc. |
Modulators of malat1 expression
|
|
CA3135180A1
(en)
|
2019-03-29 |
2020-10-08 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating ube3a-ats
|
|
US20220177423A1
(en)
|
2019-04-18 |
2022-06-09 |
Translate Bio, Inc. |
Cystine cationic lipids
|
|
ES2972014T3
(es)
|
2019-04-22 |
2024-06-10 |
Translate Bio Inc |
Lípidos catiónicos de tioéster
|
|
US12453759B2
(en)
|
2019-05-03 |
2025-10-28 |
Translate Bio, Inc. |
Di-thioester cationic lipids
|
|
EP3968952A1
(de)
|
2019-05-14 |
2022-03-23 |
Translate Bio, Inc. |
Verbessertes verfahren zur herstellung von mrna-beladenen lipidnanopartikeln
|
|
SG11202112350XA
(en)
|
2019-05-15 |
2021-12-30 |
Translate Bio Inc |
Methods for purification of messenger rna
|
|
WO2020243540A1
(en)
|
2019-05-31 |
2020-12-03 |
Translate Bio, Inc. |
Macrocyclic lipids
|
|
WO2020257611A1
(en)
|
2019-06-21 |
2020-12-24 |
Translate Bio, Inc. |
Cationic lipids comprising an hydroxy moiety
|
|
AU2020297606B2
(en)
|
2019-06-21 |
2026-04-02 |
Translate Bio, Inc. |
Tricine and citric acid lipids
|
|
CA3144644A1
(en)
|
2019-06-21 |
2020-12-24 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
|
ES2992127T3
(es)
|
2019-07-08 |
2024-12-09 |
Translate Bio Inc |
Nanopartículas lipídicas cargadas de ARNm mejoradas y sus procesos de fabricación
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
WO2021016430A1
(en)
|
2019-07-23 |
2021-01-28 |
Translate Bio, Inc. |
Stable compositions of mrna-loaded lipid nanoparticles and processes of making
|
|
ES3048358T3
(en)
|
2019-07-26 |
2025-12-10 |
Ionis Pharmaceuticals Inc |
Compounds and methods for modulating gfap
|
|
EP4003397B1
(de)
|
2019-07-30 |
2025-02-26 |
Translate Bio, Inc. |
Behandlung von zystischer fibrose durch verabreichung von vernebelter mrna, die cftr codiert
|
|
KR20220062517A
(ko)
|
2019-08-15 |
2022-05-17 |
아이오니스 파마수티컬즈, 인코포레이티드 |
결합 변형된 올리고머 화합물 및 이의 용도
|
|
US12516085B2
(en)
|
2019-09-19 |
2026-01-06 |
Sanford Burnham Prebys Medical Discovery Institute |
Methods and compositions for treating Myc-driven cancers
|
|
EP4034564A4
(de)
|
2019-09-23 |
2023-12-13 |
Twist Bioscience Corporation |
Variante nukleinsäurebibliotheken für einzeldomänenantikörper
|
|
US12091777B2
(en)
|
2019-09-23 |
2024-09-17 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for CRTH2
|
|
BR112022011235A2
(pt)
|
2019-12-09 |
2022-12-13 |
Twist Bioscience Corp |
Bibliotecas de variantes de ácido nucleico para receptores de adenosina
|
|
US12053551B2
(en)
|
2019-12-20 |
2024-08-06 |
Translate Bio, Inc. |
Process of preparing mRNA-loaded lipid nanoparticles
|
|
KR20220142432A
(ko)
|
2019-12-20 |
2022-10-21 |
트랜슬레이트 바이오 인코포레이티드 |
메신저 rna의 직장 전달
|
|
WO2021142245A1
(en)
|
2020-01-10 |
2021-07-15 |
Translate Bio, Inc. |
Compounds, pharmaceutical compositions and methods for modulating expression of muc5b in lung cells and tissues
|
|
AU2021218671A1
(en)
|
2020-02-10 |
2022-10-06 |
Translate Bio, Inc. |
Methods and compositions for messenger RNA purification
|
|
WO2021173840A1
(en)
|
2020-02-25 |
2021-09-02 |
Translate Bio, Inc. |
Improved processes of preparing mrna-loaded lipid nanoparticles
|
|
PH12022552258A1
(en)
|
2020-02-28 |
2023-11-20 |
Ionis Pharmaceuticals Inc |
Compounds and methods for modulating smn2
|
|
CN115667207B
(zh)
|
2020-04-01 |
2025-09-16 |
翻译生物公司 |
基于酚酸脂质的阳离子脂质
|
|
BR112022019889A2
(pt)
|
2020-04-02 |
2023-03-07 |
Mirecule Inc |
Inibição direcionada com o uso de oligonucleotídeos modificados geneticamente
|
|
KR20230005933A
(ko)
|
2020-05-01 |
2023-01-10 |
아이오니스 파마수티컬즈, 인코포레이티드 |
Atxn1을 조정하는 화합물 및 방법
|
|
EP4146680A1
(de)
|
2020-05-07 |
2023-03-15 |
Translate Bio, Inc. |
Zusammensetzung und verfahren zur behandlung von primärer ziliardyskinesie
|
|
US12514932B2
(en)
|
2020-05-14 |
2026-01-06 |
Translate Bio, Inc. |
PEG lipidoid compounds
|
|
EP4149425A1
(de)
|
2020-05-15 |
2023-03-22 |
Translate Bio, Inc. |
Lipidnanopartikelformulierungen zur mrna-abgabe
|
|
CA3178965A1
(en)
|
2020-05-15 |
2021-11-18 |
Christian COBAUGH |
Messenger rna encoding cas9 for use in genome-editing systems
|
|
IL298530A
(en)
|
2020-06-29 |
2023-01-01 |
Ionis Pharmaceuticals Inc |
Compounds and methods for modulating plp1
|
|
US20240307556A1
(en)
|
2020-07-02 |
2024-09-19 |
Maritime Therapeutics, Inc. |
Compositions and methods for reverse gene therapy
|
|
KR20230043914A
(ko)
|
2020-07-28 |
2023-03-31 |
아이오니스 파마수티컬즈, 인코포레이티드 |
App 발현을 감소시키기 위한 화합물 및 방법
|
|
TW202221123A
(zh)
|
2020-08-07 |
2022-06-01 |
美商Ionis製藥公司 |
調節ｓｃｎ２ａ之化合物及方法
|
|
KR20230092914A
(ko)
|
2020-09-23 |
2023-06-26 |
트랜슬레이트 바이오 인코포레이티드 |
Tes계 양이온성 지질
|
|
EP4216933B1
(de)
|
2020-09-23 |
2024-09-18 |
Translate Bio, Inc. |
Kationische lipide auf piperazinbasis
|
|
JP2023544167A
(ja)
|
2020-10-01 |
2023-10-20 |
トランスレイト バイオ， インコーポレイテッド |
メッセンジャーｒｎａの精製のための方法
|
|
WO2022076562A1
(en)
|
2020-10-06 |
2022-04-14 |
Translate Bio, Inc. |
Improved process and formulation of lipid nanoparticles
|
|
US20220133631A1
(en)
|
2020-10-12 |
2022-05-05 |
Translate Bio, Inc. |
Process of preparing ice-based lipid nanoparticles
|
|
WO2022078569A1
(en)
|
2020-10-12 |
2022-04-21 |
Eberhard Karls Universität Tübingen |
Artificial nucleic acids for rna editing
|
|
US20220110884A1
(en)
|
2020-10-12 |
2022-04-14 |
Translate Bio, Inc. |
Process of preparing mrna-loaded lipid nanoparticles
|
|
US11771652B2
(en)
|
2020-11-06 |
2023-10-03 |
Sanofi |
Lipid nanoparticles for delivering mRNA vaccines
|
|
JP7820374B2
(ja)
|
2020-11-18 |
2026-02-25 |
アイオーニス ファーマシューティカルズ， インコーポレーテッド |
アンジオテンシノーゲン発現を調節するための化合物及び方法
|
|
US12018261B2
(en)
|
2020-12-18 |
2024-06-25 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating factor XII
|
|
WO2022178438A1
(en)
|
2021-02-22 |
2022-08-25 |
Duke University |
Non-immunogenic poegma-aptamer conjugates
|
|
WO2022183015A1
(en)
|
2021-02-26 |
2022-09-01 |
The Regents Of The University Of California |
Assembled three-dimensional cultures of human neurons and glia and their use
|
|
TW202309002A
(zh)
|
2021-04-15 |
2023-03-01 |
美商轉譯生技公司 |
基於「古德」緩衝液的陽離子脂質
|
|
WO2022240960A1
(en)
|
2021-05-14 |
2022-11-17 |
Crispr Therapeutics Ag |
Mrna large scale synthesis and purification
|
|
US20240279828A1
(en)
|
2021-05-31 |
2024-08-22 |
Genscript Usa Inc. |
Electrografted films for dna synthesis
|
|
US20240262878A1
(en)
|
2021-06-07 |
2024-08-08 |
The Board Of Trustees Of The University Of Illinois |
Photoactivatable gasdermin proteins
|
|
EP4355759A4
(de)
|
2021-06-18 |
2026-05-13 |
Ionis Pharmaceuticals Inc |
Verbindungen und verfahren zur reduzierung der ifnar1-expression
|
|
WO2022264109A1
(en)
|
2021-06-18 |
2022-12-22 |
Sanofi |
Multivalent influenza vaccines
|
|
CN117677698A
(zh)
|
2021-07-14 |
2024-03-08 |
米雷楚来股份有限公司 |
用于神经肌肉障碍的寡核苷酸及其组合物
|
|
AU2022336615A1
(en)
|
2021-09-02 |
2024-04-11 |
Sanofi Pasteur Inc. |
Compositions and methods for rna affinity purification
|
|
WO2023035003A1
(en)
|
2021-09-03 |
2023-03-09 |
Elegen Corp. |
Multi-way bead-sorting devices, systems, and methods of use thereof using pressure sources
|
|
WO2023059412A1
(en)
|
2021-10-05 |
2023-04-13 |
Microsoft Technology Licensing, Llc |
Regulation of dna synthesis by nucleotides linked to protecting groups
|
|
CA3234107A1
(en)
|
2021-10-05 |
2023-04-13 |
Florent PERAL |
Methods for freezing and freeze-drying lipid nanoparticles (lnps) and lnps obtained with the same
|
|
US20250230511A1
(en)
|
2021-10-29 |
2025-07-17 |
Sana Biotechnology, Inc. |
Methods and reagents for amplifying viral vector nucleic acid products
|
|
TW202346593A
(zh)
|
2021-11-05 |
2023-12-01 |
法商賽諾菲公司 |
呼吸道融合病毒rna疫苗
|
|
AU2022388747A1
(en)
|
2021-11-10 |
2024-06-20 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
|
CA3239417A1
(en)
|
2021-11-30 |
2023-06-08 |
Yvonne CHAN |
Human metapneumovirus vaccines
|
|
CN119095613A
(zh)
|
2021-12-17 |
2024-12-06 |
赛诺菲 |
莱姆病rna疫苗
|
|
CN118829624A
(zh)
|
2022-01-17 |
2024-10-22 |
赛诺菲 |
脂质化合物及其用途
|
|
AU2023220523A1
(en)
|
2022-02-21 |
2024-09-12 |
Lepu Biopharma Co., Ltd. |
Anti-5t4 antibodies and uses thereof
|
|
JP2025509507A
(ja)
|
2022-03-16 |
2025-04-11 |
トランスレイト バイオ， インコーポレイテッド |
非対称ピペラジン系カチオン性脂質
|
|
EP4499655A1
(de)
|
2022-03-28 |
2025-02-05 |
F. Hoffmann-La Roche AG |
Synthese isomerenreiner phosphoramidite auf polyolbasis
|
|
JP2025512049A
(ja)
|
2022-04-13 |
2025-04-16 |
サノフイ |
「ｇｏｏｄ」緩衝液ベースのカチオン性脂質
|
|
CN119522105A
(zh)
|
2022-05-06 |
2025-02-25 |
赛诺菲 |
核酸疫苗的信号序列
|
|
WO2023242425A1
(en)
|
2022-06-17 |
2023-12-21 |
Sanofi |
Compositions and methods for circular rna affinity purification
|
|
EP4547757A2
(de)
|
2022-06-28 |
2025-05-07 |
F. Hoffmann-La Roche AG |
Fluoreszierende farbstoffe mit grosser stokes-verschiebung
|
|
US12129460B2
(en)
|
2022-07-29 |
2024-10-29 |
Sanofi |
Methods for ethanol-free mRNA purification
|
|
EP4577236A1
(de)
|
2022-08-22 |
2025-07-02 |
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. |
Impfstoffe gegen coronaviren
|
|
CN120239607A
(zh)
|
2022-09-23 |
2025-07-01 |
Ionis制药公司 |
用于降低mecp2表达的化合物和方法
|
|
EP4360657A1
(de)
|
2022-10-28 |
2024-05-01 |
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal |
Mir-326 zur behandlung von krebs
|
|
JP2025536595A
(ja)
|
2022-11-04 |
2025-11-07 |
サノフィ パスツール インコーポレイテッド |
メッセンジャーｒｎａテール付加の方法
|
|
AU2023374764A1
(en)
|
2022-11-04 |
2025-06-19 |
Sanofi Pasteur Inc. |
Respiratory syncytial virus rna vaccination
|
|
WO2024099575A1
(en)
|
2022-11-11 |
2024-05-16 |
Eberhard Karls Universität Tübingen |
Artificial nucleic acids for site-directed editing of a target rna
|
|
EP4622630A1
(de)
|
2022-11-21 |
2025-10-01 |
Translate Bio, Inc. |
Zusammensetzungen aus trockenpulverformulierungen von messenger-rna und verfahren zur verwendung davon
|
|
EP4634207A1
(de)
|
2022-12-15 |
2025-10-22 |
Sanofi Pasteur Inc. |
Rekombinante capping enzyme aus mrna
|
|
AU2023408649A1
(en)
|
2022-12-22 |
2025-08-07 |
Sanofi Pasteur Inc. |
Bis-ester and amide cationic lipids
|
|
EP4623103B1
(de)
|
2023-01-06 |
2026-02-04 |
DNA Script |
Verfahren zur korrekten gewinnung von nukleinsäuren
|
|
GB202300915D0
(en)
|
2023-01-20 |
2023-03-08 |
Sisaf Ltd |
mRNA COMPOSITIONS
|
|
JP2026504797A
(ja)
|
2023-03-02 |
2026-02-10 |
サノフィ・パスツール |
クラミジア（Ｃｈｌａｍｙｄｉａ）の治療に使用するための組成物
|
|
WO2024206592A2
(en)
|
2023-03-31 |
2024-10-03 |
The Regents Of The University Of California |
Induced pluripotent stem cell model of fibrous dysplasia/mccune-albright syndrome and methods of use
|
|
UY40699A
(es)
|
2023-04-05 |
2024-08-30 |
Ionis Pharmaceuticals Inc |
Compuestos y métodos para reducir la expresión de pln
|
|
MX2025012337A
(es)
|
2023-04-17 |
2026-02-03 |
Sanofi Pasteur Inc |
Formulaciones de polvo seco reconstituibles y métodos de uso de las mismas
|
|
WO2024228121A1
(en)
|
2023-05-02 |
2024-11-07 |
The University Of Tokyo |
Long interspersed nuclear element r2 for target-specific gene delivery
|
|
WO2024231727A1
(en)
|
2023-05-05 |
2024-11-14 |
Sanofi |
Compositions for use in treatment of acne
|
|
TW202508620A
(zh)
|
2023-05-10 |
2025-03-01 |
尼可拉斯 克拉克 |
呼吸道mrna組合疫苗
|
|
CN121568920A
(zh)
|
2023-06-12 |
2026-02-24 |
赛诺菲 |
具有芳香族头基团的基于三(羟甲基)甲基甘氨酸和柠檬酸的阳离子脂质
|
|
MX2025015001A
(es)
|
2023-06-12 |
2026-02-03 |
Sanofi Sa |
Lipidos cationicos basados en tricina y acido citrico
|
|
EP4724456A1
(de)
|
2023-06-12 |
2026-04-15 |
Sanofi |
Kationische lipide auf sterolbasis mit aromatischen kopfgruppen
|
|
EP4735450A1
(de)
|
2023-06-28 |
2026-05-06 |
Sanofi Pasteur, Inc. |
Dianhydrohexitolbasierte ionisierbare lipide zur nukleinsäurefreisetzung
|
|
EP4734960A1
(de)
|
2023-06-28 |
2026-05-06 |
Sanofi Pasteur Inc. |
Sterolanaloga in lipidnanopartikelformulierungen
|
|
KR20260040011A
(ko)
|
2023-06-28 |
2026-03-23 |
사노피 백신즈 유에스 인크. |
핵산 전달을 위한 헬퍼 지질
|
|
CN121889496A
(zh)
|
2023-07-19 |
2026-04-17 |
赛诺菲 |
牙龈卟啉单胞菌抗原构建体
|
|
WO2025051975A1
(en)
|
2023-09-06 |
2025-03-13 |
Sanofi |
Modified influenza b hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
IL327100A
(en)
|
2023-09-15 |
2026-05-01 |
Praxis Prec Medicines Inc |
Alsonarsen/PRAX-22 for use in the treatment of SCN2A-related disorders
|
|
WO2025061967A1
(en)
|
2023-09-20 |
2025-03-27 |
Sanofi |
"good" buffer-based cationic lipids for nucleic acid delivery
|
|
AU2024361969A1
(en)
|
2023-10-16 |
2026-04-23 |
The University Of Tokyo |
R2 retrotransposons for gene writing
|
|
IL327356A
(en)
|
2023-10-18 |
2026-05-01 |
Amgen Inc |
Quantitative assessment of mRNA transcript levels using DDPCR for initial pool characterization and evaluation of single-cell clones in the cell line development process
|
|
EP4553174A1
(de)
|
2023-11-08 |
2025-05-14 |
Consejo Superior De Investigaciones Científicas |
Verfahren zur bestimmung der thymusfunktion durch ein tröpfchen-digital-pcr-system
|
|
WO2025134071A1
(en)
|
2023-12-22 |
2025-06-26 |
Sanofi |
Malic and glutaric acid based ionizable lipids
|
|
WO2025141521A1
(en)
|
2023-12-29 |
2025-07-03 |
Sanofi |
Lipids having dendritic moieties
|
|
WO2025163146A1
(en)
|
2024-01-31 |
2025-08-07 |
Sanofi |
Methods for ethanol-free mrna purification
|
|
WO2025196065A1
(en)
|
2024-03-20 |
2025-09-25 |
Sanofi |
Novel homocysteine based lipids and their use for delivery of nucleic acids
|
|
WO2025210592A1
(en)
|
2024-04-05 |
2025-10-09 |
Sanofi Pasteur Inc. |
Muscle cell lnp-mrna quality control assays
|
|
WO2025217194A1
(en)
|
2024-04-09 |
2025-10-16 |
Typewriter Therapeutics, Inc. |
Repeat dosing of retrotransposons
|
|
WO2025250906A1
(en)
|
2024-05-30 |
2025-12-04 |
Aera Therapeutics, Inc. |
Process for preparation of targeted lipid nanoparticles
|
|
WO2026006524A2
(en)
|
2024-06-26 |
2026-01-02 |
Sanofi Pasteur Inc. |
Bis-ester and amide cationic lipids
|
|
WO2026003373A1
(en)
|
2024-06-28 |
2026-01-02 |
Sanofi |
Phenolic acid lipid based cationic lipids
|
|
WO2026008743A1
(en)
|
2024-07-02 |
2026-01-08 |
Sanofi Pasteur Inc. |
Water-soluble polyanionic polymer as adjuvant for carrier-formulated nucleic acid
|
|
WO2026027730A1
(en)
|
2024-07-31 |
2026-02-05 |
Sanofi |
Modified h5 influenza hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
WO2026033123A1
(en)
|
2024-08-08 |
2026-02-12 |
Sanofi Pasteur Inc. |
Lipid nanoparticle formulations for mrna delivery
|
|
WO2026053147A1
(en)
|
2024-09-05 |
2026-03-12 |
Sanofi Pasteur Inc. |
Helper lipids and lnp compositions comprising same
|
|
WO2026052773A1
(en)
|
2024-09-06 |
2026-03-12 |
Sanofi |
Modified influenza a hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
WO2026052826A1
(en)
|
2024-09-09 |
2026-03-12 |
Roche Diagnostics Gmbh |
Methods for producing fluorescent dyes
|
|
WO2026094020A1
(en)
|
2024-11-04 |
2026-05-07 |
Sanofi Pasteur Inc. |
Phthalic acid and vanillic acid based cationic lipids
|